MIRA INFORM REPORT

 

 

Report No. :

333541

Report Date :

25.07.2015

 

IDENTIFICATION DETAILS

 

Name :

CEVA SANTE ANIMALE

 

 

Registered Office :

10 Av De La Ballastiere, 33500 Libourne

 

 

Country :

France

 

 

Financials (as on) :

31.12.2012

 

 

Date of Incorporation :

August 1988

 

 

Com. Reg. No.:

301 763 405

 

 

Legal Form :

Public limited company with board of directors

 

 

Line of Business :

Subject is manufacture of pharmaceutical preparations

 

 

No. of Employee :

500 to 999

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

France

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

FRANCE - ECONOMIC OVERVIEW

 

The French economy is diversified across all sectors. The government has partially or fully privatized many large companies, including Air France, France Telecom, Renault, and Thales. However, the government maintains a strong presence in some sectors, particularly power, public transport, and defense industries. With more than 84 million foreign tourists per year, France is the most visited country in the world and maintains the third largest income in the world from tourism. France's leaders remain committed to a capitalism in which they maintain social equity by means of laws, tax policies, and social spending that mitigate economic inequality. France's real GDP increased by 0.4% in 2014. The unemployment rate (including overseas territories) increased from 7.8% in 2008 to 10.4% in the fourth quarter of 2014. Youth unemployment in metropolitan France decreased from a high of 25.4% in the fourth quarter of 2012 to 24.3% in the fourth quarter of 2014. Lower-than-expected growth and high spending have strained France's public finances. The budget deficit rose sharply from 3.3% of GDP in 2008 to 7.5% of GDP in 2009 before improving to 4% of GDP in 2014, while France's public debt rose from 68% of GDP to more than 95% in 2014, and may hit 100% by 2016. Elected on a conventionally leftist platform, President Francois HOLLANDE surprised and angered many supporters with a January 2014 speech announcing a sharp change in his economic policy, recasting himself as a liberalizing reformer. The government's budget for 2014 shifted the balance of fiscal consolidation from taxes to a total of $24 billion in spending cuts. In December 2014, HOLLANDE announced additional reforms, including a plan to extend commercial business hours, liberalize professional services, and sell off $6.2-12.4 billion in state owned assets. France’s tax burden remains well above the EU average and income tax cuts over the past decade are being partly reversed, particularly for higher earners. The top rate of income tax is 41%. The government is allowing a 75% payroll tax on salaries over $1.24 million to lapse.

 

Source : CIA

 

 

Company name

 

CEVA SANTE ANIMALE

 

 

SIRET

301 763 405 00067

Name

CEVA SANTE ANIMALE

Acronym

-

Trade name

-

Status

Economically active

Postal Address

CEVA SANTE ANIMALE
10 AV DE LA BALLASTIERE
33500 LIBOURNE

Share Capital

40,682,182 Euros

Incorporiation Date

08/1988

Activity (APE)

Manufacture of pharmaceutical preparations (2120Z)

RCS Registration

RCS Libourne B 301 763 405

Formation Date

06/1981

EUR VAT Number

FR91301763405

Deregistration Date

-

Last account Date

31/12/2012

Court Registry Number

19 8 9B00043

Telephone

02 40 87 35 78

Registration Court

Libourne (33)

Fax

-

Nationality

France

 

Legal form

Public limited company with board of directors

Currency

Euros

 

 

Key Financials

 

YEAR TO DATE

TURNOVER

GROSS OPERATING SURPLUS

SHAREHOLDER'S EQUITY

NET RESULT

EMPLOYEES

31/12/2012

271,913,000 €

13.50% Turnover

195,568,000 €

31,930,000 €

-

31/12/2011

259,250,000 €

16.76% Turnover

169,275,000 €

24,369,000 €

-

31/12/2010

237,913,000 €

17.35% Turnover

150,601,000 €

33,915,000 €

-

 

 

Ultimate Holding Company

 

Name

Safe Number

Country

Company Number

FINANCIERE CHOPIN

FR09615637

497715748

Affiliation links.

4 companies in the international Group Structure from 4 countries.

 

 

Directors

 

Current Directors

5

 

Preferential Right

 

No social security and tax office preferential right to date

 

 

Payment Information Summary – Trade Payment Data

 

Total number of Invoices available

143

Total number of Invoices paid within or up to 30 days after the due date

112

Total number of Invoices paid more than 30 days after the dues date

22

Total number of Invoices currently outstanding where the due date has not yet been reached

9

Total number of Invoices currently outstanding beyond the due date

0

 

 

Establishment Details

 

Type of Establishment

Head Office

Production Role

-

APE/NAF Code

2120Z

Activity

Manufacture of pharmaceutical preparations

Formation Date

12/1988

Reason for Formation

Other

Closure Date

-

Reason for Closure

-

Reactivation Date

-

Seasonality

-

Activity Nature

-

Activity Location

Other

Trading Address

10 AVENUE DE LA BALLASTIERE 
33500 LIBOURNE

Department

Gironde (33)

Location Surface

-

District

5

City

LIBOURNE

Status

Economically active

Business Pages FT®

LABORATOIRES ET CLINIQUES VETERINAIRES

Region

Aquitaine

Area

30

Size of Urban Area

-

 

 

Ultimate Parent(s)

 

1 ultimate parent company/companies for this company

 

Company Name

Activity (APE)

APE/NAF Code

City

Post Code

FINANCIERE CHOPIN

Activités des sociétés holding

6420Z

PARIS 9

75009

 

 

Other Establishment(s)

 

Regionality

Legal unit with multiple establishments in many areas having at least 50% of workforce in same area

Mono-activity status

Legal unit having all establishments with the same main activity

Branches

4 branch entities in this company

 

 

Company Name

Company Type

APE/NAF Code

Activity

City

Post Code

CEVA SANTE ANIMALE

Head Office

2120Z

Manufacture of pharmaceutical preparations

LIBOURNE

33500

CEVA SANTE ANIMALE

Branch

2120Z

Manufacture of pharmaceutical preparations

LOUDEAC

22600

CEVA SANTE ANIMALE

Branch

2120Z

Manufacture of pharmaceutical preparations

PARIS 9

75009

CEVA SANTE ANIMALE

Branch

2120Z

Manufacture of pharmaceutical preparations

LOUDEAC

22600

CEVA SANTE ANIMALE

Branch

2120Z

Manufacture of pharmaceutical preparations

PARIS 9

75009

 

 

Workforces

 

Workforce at address

500 to 999 employees

Company workforce

500 to 999 employees

 

 

Commentary

 

The comments are ordered according to the class of risk. Companies are compared with regard to other companies of the same type. Thus a positive comment for one category can be negative for another or can change depending on its value. This is a purely statistical decision.

 

The shareholder's equity is 195,568,000 €

The creditor days are 27.48

The increase of tangible fixed assets over the last two accounting periods is 28 %

The liabilities are 336,095,000 €

The net current assets are 151,199,000 €

The net turnover is 271,913,000 €

The pre-tax profit is 37,065,000 €

The risk provisions are 4,398,000 €

The total assets are 544,286,000 €

Low risk workforce size

The company has 6 directors

Industry code with low risk rating

Department code with low risk rating

The ratio total assets to total liabilities is 1.60

The stock to turnover ratio is 11.84

The return on total assets employed is 6.81

 

 

Industry comparison

 

Activity (APE)

Manufacture of pharmaceutical preparations (2120Z)

Industry average credit rating

51

Industry average credit limit

544,306

 

 

Collective procedures

 

No judgment information for the company

 

 

Preferential rights details and history

 

Summary of preferential rights

 

Company monitored since

02/06/2009

Status of Monitoring

No social security and tax office preferential right to date

 

 

Group Data

 

Ultimate parent company

FINANCIERE CHOPIN

Direct parent

FINANCIERE CHOPIN - 99.13 %

Group – Number of companies

41

Linkages – Number of companies

4

Number of countries

4

 

 

NAME

SIREN

PARTS

LAST ACCOUNT PUBLISHED

1

FINANCIERE CHOPIN

497715748

-

31/12/2013

2

CEVA SANTE ANIMALE

301763405

99.13 %

31/12/2012

3

CEVA ANIMAL HEALTH BULGARIA

-

Majority

-

CEVA HELLAS

-

100 %

-

CEVA SANTÉ ANIMALE RUMANIA

-

Majority

-

MDB

-

Majority

-

CEVA SANTÉ ANIMALE B.V.

24222623

100 %

31/12/2013

CEVA VETEM

-

100 %

-

CEVA SALUD ANIMAL SAC

-

100 %

-

CEVA ANIMAL HEALTH SLOVAKIA

-

100 %

-

CEVA ANCHORPHARM (PTY) LTD

-

Majority

-

CEVA ANIMAL HEALTH POLSKA

-

100 %

-

CEVA KEMIA SA DE CV

-

Majority

-

CEVA SALUD ANIMAL

641233

100 %

31/12/2013

VETBRANDS

-

Majority

-

CEVA ANIMAL HEALTH LIMITED

03085474

100 %

31/12/2013

CEVA PHYLAXIA

-

100 %

-

CEVA ANIMAL HEALTH PHILIPPINES

-

100 %

-

CEVA SANTE ANIMALE SA

418894795

100 %

31/12/2014

BIOMUNE, INC

-

Majority

-

CEVA SANTÉ ANIMALE - AOC

-

100 %

-

CEVA ANIMAL HEALTH AB

5566289202

100 %

31/12/2013

CEVA SANTÉ ANIMALE LLC

-

100 %

-

CEVA SOPHAVET

-

Majority

-

CEVA ROSCO ANIMAL HEALTH

-

100 %

-

3

SOGEVAL

712005107

100 %

31/12/2013

4

SOGEVAL LABORATORIES

-

100 %

-

THESEO

481710051

100 %

31/12/2013

SOGEVAL DANEMARK

-

100 %

-

CEVA TIERGESUNDHEIT GMBH

HRB 21959

100 %

31/12/2013

CEVA ANIMAL HEALTH INDONÉSIE

-

100 %

-

CEVA SANTÉ ANIMALE UKRAINE

-

Majority

-

CEVA VETERINRTLIK URUNLERI TICARET

-

Majority

-

CEVA LAVAL

-

Majority

-

CEVA SAUDE ANIMAL LTDA

-

100 %

-

CEVA SAUDE ANIMAL

-

100 %

-

CEVA INTERCHEM

-

Majority

-

BULTER SALES ASSOCIATES, INC

-

Majority

-

CEVA-PHYLAXIA OLTOANYAGTERMELO

-

100 %

-

LAPROVET

316417690

100 %

31/12/2013

DESVAC

409612785

100 %

31/12/2014

 

 

Linkages

 

COMPANY NAME

SAFE NUMBER

SIREN

LAST ACCOUNT PUBLISHED

RATING

LIMIT

TURNOVER

SOGEVAL UK LIMITED

UK02597467

02937525

31/12/2013

80

340,000 £

7,003,717 £

BIOMUNE CO

US15945584

-

-

13

35,500 $

0 $

CEVA SANTE ANIMALE CEVA ANIMAL HEALTH

-

-

-

-

-

-

CEVA SANTE ANIMALE SA

-

-

-

-

-

-

 

 

Shareholder(s)

 

Name

FINANCIERE CHOPIN

Name of representative

Manager position

Administrator

Date of birth

-

Place of birth

Type

Moral person

Name at birth

 

 

Director(s)

 

Name

M. PRIKAZSKY MARC DOMINIQUE

Manager position

Chief Executive Officer, Administrator

Date of birth

26/04/1959

Place of birth

NEUILLY SUR SEINE (92051)

Type

Individual

Name at birth

Name

M. EMERY BERNARD MARIE ARMAND

Manager position

Administrator

Date of birth

06/09/1953

Place of birth

LYON (69001)

Type

Individual

Name at birth

 

Name

M. BALMES HERVÉ JEAN PIERRE

Manager position

Administrator

Date of birth

14/05/1961

Place of birth

SAINT-QUENTIN (02100)

Type

Individual

Name at birth

Name

M. KALTSATOS VASSILIOS

Manager position

Delegated managing director

Date of birth

13/02/1961

Place of birth

LARISSAC(GRECE)

Type

Individual

Name at birth

 

 

Previous Directors

 

Manager position

Title and name

Date of Birth/Place of Birth

Chief Executive Officer

M. DU MESNIL PHILIPPE

19/04/1949 - BORDEAUX

Chief Executive Officer

M. PRIKAZSKY MARC DOMINIQUE

26/04/1959 - 92 NEUILLY SUR SEINE

Chief Executive Officer

M. PRIKAZSKY MARC DOMINIQUE

26/04/1959 - 92 NEUILLY SUR SEINE

Chief Executive Officer

M. PRIKAZSKY MARC-DOMINIQUE

26/04/1959 - NEUILLY SUR SEINE

Managing director

M. LEBRETTE JEAN-PIERRE

-

Delegated managing director

M. KALTSATOS VASSILIOS

-

Delegated managing director

M. KALTSATOS VASSILIOS

12/02/1961 - LARISSA GRECE

Delegated managing director

M. KALTSATOS VASSILIOS

13/02/1961 - LARISSAC(GRECE)

Delegated managing director

M. POMMIER MICHEL

29/04/1960 - CLERMONT FERRAND

Delegated managing director

M. PRIKAZSKY MARC

-

Delegated managing director

M. PRIKAZSKY MARC-DOMINIQUE

26/04/1959 - NEUILLY SUR SEINE

Administrator

M. DU MESNIL PHILIPPE

19/04/1949 - 33 BORDEAUX

Administrator

M. DU MESNIL PHILIPPE

19/04/1949 - BORDEAUX

Administrator

M. DU MESNIL PHILIPPE

19/04/1949 - 33 BORDEAUX

Administrator

M. EMERY BERNARD MARIE ARMAND

06/09/1953 - 69 LYON

Administrator

FINANCIERE CHOPIN

09/02/1958 - PARIS

Administrator

FINANCIERE CHOPIN

09/02/1958 - PARIS

Administrator

FINANCIERE CHOPIN

08/10/1961 - MONT-DE-MARSAN

Administrator

FINANCIERE MENDELSSOHN

-

Administrator

FINANCIERE MENDELSSOHN

-

Administrator

FINANCIERE MENDELSSOHN

09/02/1958 - PARIS

Administrator

M. LEBRETTE JEAN-PIERRE

-

Administrator

M. PRIKAZSKY MARC DOMINIQUE

26/04/1959 - 92 NEUILLY SUR SEINE

Administrator

M. PRIKAZSKY MARC DOMINIQUE

26/04/1959 - 92 NEUILLY SUR SEINE

Administrator

M. PRIKAZSKY MARC-DOMINIQUE

26/04/1959 - NEUILLY SUR SEINE

Administrator

M. REVEL MOUROZ PIERRE

-

Administrator

M. REVEL MOUROZ PIERRE

08/10/1961 - MONT DE MARSAN

Administrator

M. REVEL-MOUROZ PIERRE JEROME

08/10/1961 - 40 MONT-DE-MARSAN

Administrator

M. ROLLAND GASTON

01/08/1947 - NANTES

Delegated managing director

M. KALTSATOS VASSILIOS

13/02/1961 - LARISSAC(GRECE)

 

 

Status history

 

No Status History

 

 

Recent publications in Gazettes

 

Publication date

Gazette Name

Description

29/09/2014

Bodacc C

Comptes consolidés et rapports

33 - GIRONDE

GREFFE DU TRIBUNAL DE COMMERCE DE LIBOURNE

3999 - 301763405 RCS. CEVA SANTE ANIMALE. Forme : Société anonyme. Adresse : 10 avenue de la Ballastière 33500 Libourne. Commentaires : Comptes annuels et rapports de l'exercice clos le : 31/12/2013.

10/09/2014

Bodacc C

Comptes annuels et rapports

33 - GIRONDE

GREFFE DU TRIBUNAL DE COMMERCE DE LIBOURNE

274 - 301763405 RCS. CEVA SANTE ANIMALE. Forme : Société anonyme. Adresse : 10 avenue de la Ballastière 33500 Libourne. Commentaires : Comptes annuels et rapports de l'exercice clos le : 31/12/2013.

02/09/2014

Bodacc B

Modification et mutation diverse

33 - GIRONDE

GREFFE DU TRIBUNAL DE COMMERCE DE LIBOURNE

242 - 301 763 405 RCS Libourne. CEVA SANTE ANIMALE. Forme : Société anonyme. Capital : 40682182.52 EUR. Activité : . 
Adresse du siège social : 10 avenue de la Ballastière, 33500 Libourne. 
Commentaires : modification survenue sur le capital (augmentation) et l'adresse de l'établissement.

22/08/2014

JAL

Modification of the share capital

Echos Judiciaires Girondins (Les)


Date de décision : 24/07/2014
La société : 301763405 - CEVA SANTE ANIMALE, 10 AV DE LA BALLASTIERE, 33500 LIBOURNE a subi une augmentation de son capital socialdésormais de 40 682 183 € 
Date d'effet : 24/07/2014

03/09/2013

Bodacc C

Comptes annuels et rapports

33 - GIRONDE

GREFFE DU TRIBUNAL DE COMMERCE DE LIBOURNE

2120 - 301763405 RCS. CEVA SANTE ANIMALE. Forme : Société anonyme. Adresse : 10 avenue de la Ballastière 33500 Libourne. Commentaires : Comptes annuels et rapports de l'exercice clos le : 31/12/2012.

03/09/2013

Bodacc C

Comptes consolidés et rapports

33 - GIRONDE

GREFFE DU TRIBUNAL DE COMMERCE DE LIBOURNE

2119 - 301763405 RCS. CEVA SANTE ANIMALE. Forme : Société anonyme. Adresse : 10 avenue de la Ballastière 33500 Libourne. Commentaires : Comptes annuels et rapports de l'exercice clos le : 31/12/2012.

05/12/2012

Bodacc B

Modification et mutation diverse

33 - GIRONDE

GREFFE DU TRIBUNAL DE COMMERCE DE LIBOURNE

1272 - 301 763 405 RCS Libourne. CEVA SANTE ANIMALE. Forme : Société anonyme. Administration : modification de l'Administrateur Du Mesnil, Philippe, nomination de l'Administrateur : Balmes, Hervé Jean Pierre. Capital : 40331892.34 EUR. Activité : . 
Adresse du siège social : 10 avenue de la Ballastière, 33500 Libourne. 
Commentaires : modification survenue sur l'administration.

23/11/2012

JAL

Appointment of the social representative

Courrier Français/Edition de la Gironde


Date de décision : 30/10/2012
Société faisant l'objet d'une nomination : 301763405 - CEVA SANTE ANIMALE, 10 AV DE LA BALLASTIERE, 33500 LIBOURNE 
Nominé : Monsieur Hervé BALMES, 33000 BORDEAUX
En la fonction de : Administrateur

23/11/2012

JAL

Resignation / Revocation of the social representative

Courrier Français/Edition de la Gironde


Date de décision : 30/10/2012
La société 301763405 - CEVA SANTE ANIMALE, 10 AV DE LA BALLASTIERE, 33500 LIBOURNE 
Fait l'objet du départ de Monsieur Philippe du MESNIL

22/08/2012

Bodacc C

Comptes annuels et rapports

33 - GIRONDE

GREFFE DU TRIBUNAL DE COMMERCE DE LIBOURNE

5229 - 301763405 RCS. CEVA SANTE ANIMALE. Forme : Société anonyme à conseil d'administration. Adresse : 10 avenue de la Ballastière 33500 Libourne.Commentaires : Comptes annuels et rapports de l'exercice clos le : 31/12/2011.

22/08/2012

Bodacc C

Comptes annuels, consolidés et rapports

33 - GIRONDE

GREFFE DU TRIBUNAL DE COMMERCE DE LIBOURNE

5230 - 301763405 RCS. CEVA SANTE ANIMALE. Forme : Société anonyme à conseil d'administration. Adresse : 10 avenue de la Ballastière 33500 Libourne.Commentaires : Comptes annuels et rapports de l'exercice clos le : 31/12/2011.

12/04/2011

Bodacc B

Modification et mutation diverse

33 - GIRONDE

GREFFE DU TRIBUNAL DE COMMERCE DE LIBOURNE

913 - 301 763 405 RCS Libourne. CEVA SANTE ANIMALE. Forme : Société anonyme à conseil d'administration. Administration : Président directeur général : PRIKAZSKY Marc Dominique Administrateur : DU MESNIL Philippe Administrateur : PRIKAZSKY Marc Dominique Administrateur : FINANCIERE CHOPIN, représenté par M REVEL-MOUROZ Pierre Jérôme Administrateur : EMERY Bernard Marie Armand Commissaire aux comptes titulaire : ERNST & YOUNG ET AUTRES Commissaire aux comptes titulaire : BLANC-PATIN Christine Commissaire aux comptes suppléant : AUDITEX Commissaire aux comptes suppléant : MARTINI Pierre Directeur général délégué : KALTSATOS Vassilios. Capital : 40331892.34 EUR. Activité : fabrication de produits pharmaceutiques. Adresse de l’établissement principal : 10 avenue de la Ballastière, 33500 Libourne. 
Adresse du siège social : 10 avenue de la Ballastière, 33500 Libourne. 
Commentaires : changement de représentant permanent. Date de commencement de l’activité : 30/12/1988. Date d’effet : 26/10/2010.

21/12/2010

Bodacc B

Modification et mutation diverse

33 - GIRONDE

GREFFE DU TRIBUNAL DE COMMERCE DE LIBOURNE

711 - 301 763 405 RCS Libourne. CEVA SANTE ANIMALE. Forme : Société anonyme à conseil d'administration. Administration : Président directeur général : PRIKAZSKY Marc Dominique Administrateur : DU MESNIL Philippe Administrateur : PRIKAZSKY Marc Dominique Administrateur : FINANCIERE CHOPIN, représenté par MME REMUS Caroline Administrateur : EMERY Bernard Marie Armand Commissaire aux comptes titulaire : ERNST & YOUNG ET AUTRES Commissaire aux comptes titulaire : BLANC-PATIN Christine Commissaire aux comptes suppléant : AUDITEX Commissaire aux comptes suppléant : MARTINI Pierre Directeur général délégué : KALTSATOS Vassilios. Capital : 40331892.34 EUR. Activité : fabrication de produits pharmaceutiques. Adresse de l’établissement principal : 10 avenue de la Ballastière, 33500 Libourne. 
Adresse du siège social : 10 avenue de la Ballastière, 33500 Libourne. 
Commentaires : Changement d'administrateur. Date de commencement de l’activité : 30/12/1988. Date d’effet : 26/10/2010.

10/12/2010

JAL

Appointment of the social representative

Courrier Français/Edition de la Gironde


Société faisant l'objet d'une nomination : 301763405 - CEVA SANTE ANIMALE, 10 AV DE LA BALLASTIERE, 33500 LIBOURNE 
Nominé : Monsieur Bernard EMERY, 19 Rue Oscar Balaresque, 33200 BORDEAUX
En la fonction de : Administrateur
Date d'effet : 26/10/2010

01/09/2010

Bodacc C

Comptes annuels et rapports

33 - GIRONDE

GREFFE DU TRIBUNAL DE COMMERCE DE LIBOURNE

1553 - 301763405 RCS. CEVA SANTE ANIMALE. Forme : Société anonyme à conseil d'administration. Adresse : 10 avenue de la Ballastière 33500 Libourne.Commentaires : Comptes annuels et rapports de l'exercice clos le : 31/12/2009.

12/08/2010

Bodacc B

Modification et mutation diverse

33 - GIRONDE

GREFFE DU TRIBUNAL DE COMMERCE DE LIBOURNE

786 - 301 763 405 RCS Libourne. CEVA SANTE ANIMALE. Forme : Société anonyme à conseil d'administration. Administration : Président directeur général : PRIKAZSKY Marc Dominique Administrateur : DU MESNIL Philippe Administrateur : PRIKAZSKY Marc Dominique Administrateur : REVEL-MOUROZ Pierre Jérôme Administrateur : FINANCIERE CHOPIN, représenté par MME REMUS Caroline Commissaire aux comptes titulaire : ERNST & YOUNG ET AUTRES Commissaire aux comptes titulaire : BLANC-PATIN Christine Commissaire aux comptes suppléant : AUDITEX Commissaire aux comptes suppléant : MARTINI Pierre Directeur général délégué : KALTSATOS Vassilios. Capital : 40331892.34 EUR. Activité : fabrication de produits pharmaceutiques. Adresse de l’établissement principal : 10 avenue de la Ballastière, 33500 Libourne. 
Adresse du siège social : 10 avenue de la Ballastière, 33500 Libourne. 
Commentaires : changement de commissaires aux comptes. Date de commencement de l’activité : 30/12/1988. Date d’effet : 22/06/2010.

24/12/2009

Bodacc B

Modification et mutation diverse

33 - GIRONDE

GREFFE DU TRIBUNAL DE COMMERCE DE LIBOURNE

358 - 301 763 405 RCS Libourne. CEVA SANTE ANIMALE. Forme : Société anonyme à conseil d'administration. Administration : Président directeur général : PRIKAZSKY Marc Dominique Administrateur : DU MESNIL Philippe Administrateur : PRIKAZSKY Marc Dominique Administrateur : REVEL-MOUROZ Pierre Jérôme Administrateur : FINANCIERE CHOPIN, représenté par MME REMUS Caroline Commissaire aux comptes titulaire : ERNST ET YOUNG AUDIT Commissaire aux comptes titulaire : BLANC-PATIN Christine Commissaire aux comptes suppléant : MARROT Frédéric Commissaire aux comptes suppléant : MARTINI Pierre Directeur général délégué : KALTSATOS Vassilios. Capital : 40331892.34 EUR. Activité : fabrication de produits pharmaceutiques. Adresse de l’établissement principal : 10 avenue de la Ballastière, 33500 Libourne. 
Adresse du siège social : 10 avenue de la Ballastière, 33500 Libourne. 
Commentaires : CHANGEMENT DE CRE AUX COMPTEST TITULAIRE ET SUPPLEANT. Date de commencement de l’activité : 30/12/1988. Date d’effet :17/11/0209.

18/12/2009

Bodacc B

Modification et mutation diverse

33 - GIRONDE

GREFFE DU TRIBUNAL DE COMMERCE DE LIBOURNE

902 - 301 763 405 RCS Libourne. CEVA SANTE ANIMALE. Forme : Société anonyme à conseil d'administration. Administration : Président directeur général : PRIKAZSKY Marc Dominique Administrateur : DU MESNIL Philippe Administrateur : FINANCIERE MENDELSSOHN, représenté par MME REMUS Caroline Administrateur : PRIKAZSKY Marc Dominique Administrateur : REVEL-MOUROZ Pierre Jérôme Commissaire aux comptes titulaire : ERNST ET YOUNG AUDIT Commissaire aux comptes suppléant : MARROT Frédéric Directeur général délégué : KALTSATOS Vassilios. Capital : 40331892.34 EUR. Activité :fabrication de produits pharmaceutiques. Adresse de l’établissement principal : 10 avenue de la Ballastière, 33500 Libourne. 
Adresse du siège social : 10 avenue de la Ballastière, 33500 Libourne. 
Commentaires : départ du directeur général. Date de commencement de l’activité : 30/12/1988. Date d’effet : 30/10/2009.

30/07/2009

Bodacc C

Comptes annuels et rapports

33 - GIRONDE

GREFFE DU TRIBUNAL DE COMMERCE DE LIBOURNE

1767 - 301763405 RCS. CEVA SANTE ANIMALE. Forme : Société Anonyme à conseil d'administration. Adresse : 10 avenue de la Ballastière 33500 Libourne.Commentaires : Comptes annuels et rapports de l'exercice clos le : 31/12/2008.

22/05/2009

Bodacc B

Modification et mutation diverse

33 - GIRONDE

GREFFE DU TRIBUNAL DE COMMERCE DE LIBOURNE

310 - 301 763 405 RCS Libourne. CEVA SANTE ANIMALE. Forme : Société anonyme à conseil d'administration. Administration : Président directeur général : PRIKAZSKY Marc Dominique. Administrateur : DU MESNIL Philippe. Administrateur : FINANCIERE MENDELSSOHN, représenté par MME REMUS Caroline. Administrateur : PRIKAZSKY Marc Dominique. Administrateur : REVEL-MOUROZ Pierre Jérôme. Commissaire aux comptes titulaire : ERNST ET YOUNG AUDIT. Commissaire aux comptes suppléant : MARROT Frédéric. Directeur général délégué : POMMIER Michel René. Directeur général délégué : KALTSATOS Vassilios. Capital : 40331892.34 EUR. Activité : fabrication de produits pharmaceutiques. Adresse de l’établissement principal : 10 avenue de la Ballastière, 33500 Libourne. 
Adresse du siège social : 10 avenue de la Ballastière, 33500 Libourne. 
Commentaires : CHANGEMENT D'ADMINISTRATEUR + CHANGEMENT DE PDG. Date de commencement de l’activité : 30/12/1988. Date d’effet :13/03/2009.

04/01/2009

Bodacc B

Modification et mutation diverse

33 - GIRONDE

GREFFE DU TRIBUNAL DE COMMERCE DE LIBOURNE

630 - 301 763 405 RCS Libourne. CEVA SANTE ANIMALE. Forme : Société anonyme à conseil d'administration. Administration : Président directeur général : DU MESNIL Philippe. Administrateur : DU MESNIL Philippe. Administrateur : ROLLAND Gaston Claude Charles Philippe. Administrateur : FINANCIERE MENDELSSOHN, représenté par MME REMUS Caroline. Administrateur : REVEL-MOUROZ Pierre Jérôme. Commissaire aux comptes titulaire : ERNST ET YOUNG AUDIT. Commissaire aux comptes suppléant : MARROT Frédéric. Directeur général délégué : POMMIER Michel René. Directeur général délégué : PRIKAZSKY Marc Dominique. Directeur général délégué : KALTSATOS Vassilios. Capital : 40331892.34 EUR. Activité : fabrication de produits pharmaceutiques. Adresse de l’établissement principal : Zone Industrielle, la Ballastière, 33500 Libourne. 
Adresse du siège social : Zone Industrielle, la Ballastière, 33500 Libourne. 
Commentaires : Nomination d'un directeur général délégué. Date de commencement de l’activité : 30/12/1988. Date d’effet : 16/10/2008.

14/12/2008

Bodacc B

Modification et mutation diverse

33 - GIRONDE

GREFFE DU TRIBUNAL DE COMMERCE DE LIBOURNE

1609 - 301 763 405 RCS Libourne. CEVA SANTE ANIMALE. Forme : Société anonyme à conseil d'administration. Administration : Président directeur général : DU MESNIL Philippe. Administrateur : DU MESNIL Philippe. Administrateur : ROLLAND Gaston Claude Charles Philippe. Administrateur : FINANCIERE MENDELSSOHN, représenté par MME REMUS Caroline. Administrateur : REVEL-MOUROZ Pierre Jérôme. Commissaire aux comptes titulaire : ERNST ET YOUNG AUDIT. Commissaire aux comptes suppléant : MARROT Frédéric. Directeur général délégué : POMMIER Michel René. Directeur général délégué : PRIKAZSKY Marc Dominique. Capital : 40331892.34 EUR. Activité : fabrication de produits pharmaceutiques. Adresse de l’établissement principal : Zone Industrielle, la Ballastière, 33500 Libourne. 
Adresse du siège social : Zone Industrielle, la Ballastière, 33500 Libourne. 
Commentaires : changement de représentant permanent. Date de commencement de l’activité : 30/12/1988. Date d’effet : 15/06/2007.

14/12/2008

Bodacc B

Modification et mutation diverse

33 - GIRONDE

GREFFE DU TRIBUNAL DE COMMERCE DE LIBOURNE

1610 - 301 763 405 RCS Libourne. CEVA SANTE ANIMALE. Forme : Société anonyme à conseil d'administration. Administration : Président directeur général : DU MESNIL Philippe. Administrateur : DU MESNIL Philippe. Administrateur : ROLLAND Gaston Claude Charles Philippe. Administrateur : FINANCIERE MENDELSSOHN, représenté par MME REMUS Caroline. Administrateur : REVEL-MOUROZ Pierre Jérôme. Commissaire aux comptes titulaire : ERNST ET YOUNG AUDIT. Commissaire aux comptes suppléant : MARROT Frédéric. Directeur général délégué : POMMIER Michel René. Directeur général délégué : PRIKAZSKY Marc Dominique. Capital : 40331892.34 EUR. Activité : fabrication de produits pharmaceutiques. Adresse de l’établissement principal : Zone Industrielle, la Ballastière, 33500 Libourne. 
Adresse du siège social : Zone Industrielle, la Ballastière, 33500 Libourne. 
Commentaires : CHANGEMENT D'ADMINISTRATEUR. Date de commencement de l’activité : 30/12/1988. Date d’effet : 16/10/2008.

23/08/2008

Bodacc C

Comptes annuels et rapports

33 - GIRONDE

GREFFE DU TRIBUNAL DE COMMERCE DE LIBOURNE

3948 - 301763405 RCS. CEVA SANTE ANIMALE. Forme : Société Anonyme à conseil d'administration. Adresse : Zone Industrielle la Ballastière 33500 Libourne. Commentaires : Comptes annuels et rapports de l'exercice clos le : 31/12/2007.

24/07/2007

Bodacc C

Avis de dépôt des comptes

1340 - 301 763 405. RCS Libourne CEVA SANTE ANIMALE. Forme: Société Anonyme à Conseil d'Administration. Adresse du siège social: Zone Industrielle La Ballastière 33500 Libourne. Comptes annuels et rapports de l'exercice clos le: 31 décembre 2006.

15/12/2006

Bodacc B

Modifications et mutations diverses

0856 - RCS Libourne B 301 763 405. RC 89-B 43. CEVA SANTE ANIMALE. Forme : S.A. à conseil d'administration. Capital : 40 331 892 euros. Adresse du siège social : Z.I., La Ballastière,, 33500 Administration : P.-D.G. et administrateur : DU MESNIL (Philippe). Directeur général et administrateur : LEBRETTE (Jean, Pierre, Christian). Administrateurs : ROLLAND (Gaston, Claude, Charles, Philippe) FINANCIERE MENDELSSOHN. Commissaire aux comptes titulaire : ERNST & YOUNG AUDIT. Commissaire aux comptes suppléant : MARROT (Frédéric). Directeur général délégué : POMMIER (Michel, René). Nomination d'un directeur général délégué : PRIKAZSKY (Marc, Dominique). Etablissement principal - Activité : fabrication de produits pharmaceutiques. Adresse : Z.I., La Ballastière, 33500 Date d'effet : 30 octobre 2006.

13/07/2006

Bodacc C

Avis de dépôt des comptes

1791 - RCS Libourne B 301 763 405. RC 89-B 43. CEVA SANTE ANIMALE. Forme: S.A. à conseil d'administration . Adresse du siège social: Zone Industrielle la Ballastiere,33500 Libourne. Comptes annuels et rapports de l'exercice clos le: 31 décembre 2005.

13/06/2006

Bodacc B

Modifications et mutations diverses

0990 - RCS Libourne B 301 763 405. RC 89-B 43. CEVA SANTE ANIMALE. Forme : S.A. à conseil d'administration. Capital : 40 331 892 euros. Adresse du siège social : Z.I., La Ballastière,, 33500 Administration : P.-D.G. : DU MESNIL (Philippe). Directeur général et administrateur : LEBRETTE (Jean, Pierre, Christian). Nomination d'un directeur général délégué : POMMIER (Michel, René). Administrateurs : DU MESNIL (Philippe) ROLLAND (Gaston, Claude, Charles, Philippe) FINANCIERE MENDELSSOHN. Commissaire aux comptes titulaire : ERNST & YOUNG AUDIT. Commissaire aux comptes suppléant : MARROT (Frédéric). Etablissement principal - Activité : fabrication de produits pharmaceutiques. Adresse : Z.I., La Ballastière, 33500 Date d'effet : 8 mars 2006.

01/09/2005

Bodacc C

Avis de dépôt des comptes

472 - RCS Libourne B 301 763 405. RC 89-B 43. CEVA SANTE ANIMALE. Forme: S.A. à conseil d'administration . Adresse du siège social: Zone Industrielle la Ballastiere,33500 Libourne. Comptes annuels et rapports de l'exercice clos le: 31 décembre 2004.

26/08/2004

Bodacc B

Modifications et mutations diverses

RCS Libourne B 301763405 RC 89-B 43 CEVA SANTE ANIMALE. Forme : S.A. à conseil d'administration. Capital : 40 331 892 euros. Adresse du siège social : Z.I., La Ballastière, 33500 Libourne. Administration : P.-D.G. : DU MESNIL ( Philippe). Directeur général et administrateur : LEBRETTE (Jean, Pierre, Christian). Administrateurs : DU MESNIL (Philippe) ROLLAND (Gaston, Claude, Charles, Philippe) FINANCIERE MENDELSSOHN. Commissaire aux comptes titulaire : ERNST & YOUNG AUDIT. Commissaire aux comptes suppléant : MARROT (Frédéric). Ancienne administration : ancien commissaire aux comptes suppléant : HAZARD (Claude) Etablissement principal: Activité : fabrication de produits pharmaceutiques. Adresse : Z.I., La Ballastière, 33500 Libourne. Date d'effet : 9 juin 2004.

15/08/2004

Bodacc B

Modifications et mutations diverses

RCS Libourne B 301763405 RC 89-B 43 CEVA SANTE ANIMALE. Forme : S.A. à conseil d'administration. Capital : 40 331 892 euros. Adresse du siège social : Z.I., La Ballastière, 33500 Libourne. Administration : P.-D.G. : DU MESNIL ( Philippe). Directeur général et administrateur : LEBRETTE (Jean, Pierre, Christian). Administrateurs : DU MESNIL (Philippe) ROLLAND (Gaston, Claude, Charles, Philippe) FINANCIERE MENDELSSOHN. Commissaire aux comptes titulaire : ERNST & YOUNG AUDIT. Commissaire aux comptes suppléant : HAZARD (Claude). Ancienne administration : ancien commissaire aux comptes suppléant : CARREGA ( François) Etablissement principal: Activité : fabrication de produits pharmaceutiques. Adresse : Z.I., La Ballastière, 33500 Libourne. Date d'effet : 11 mai 1998 (régularisation).

08/06/2004

Bodacc B

Modifications et mutations diverses

RCS Libourne B 301763405 RC 89-B 43 CEVA SANTE ANIMALE. Forme : S.A. à conseil d'administration. Capital : 40 331 892 euros. Adresse du siège social : Z.I., La Ballastière, 33500 Libourne. Administration : P.-D.G. : DU MESNIL ( Philippe). Directeur général et administrateur : LEBRETTE (Jean, Pierre, Christian). Administrateurs : DU MESNIL (Philippe) ROLLAND (Gaston, Claude, Charles, Philippe) FINANCIERE MENDELSSOHN. Commissaire aux comptes titulaire : ERNST & YOUNG AUDIT. Commissaire aux comptes suppléant : CARREGA (François). Ancienne administration : ancien administrateur EMERY (Bernard) Etablissement principal: Activité : fabrication de produits pharmaceutiques. Adresse : Z.I., La Ballastière, 33500 Libourne. Date d'effet : 7 avril 2004.

20/02/2004

Bodacc B

Modifications et mutations diverses

RCS Libourne B 301763405 RC 89-B 43 CEVA SANTE ANIMALE. Forme : S.A. à conseil d'administration. Capital : 40 331 892 euros. Adresse du siège social : Z.I., La Ballastière, 33500 Libourne. Administration : P.-D.G. : DU MESNIL ( Philippe). Directeur général et administrateur : LEBRETTE (Jean, Pierre, Christian). Administrateurs : EMERY ( Bernard, Marie) DU MESNIL (Philippe) FINANCIERE MENDELSSOHN. Commissaire aux comptes titulaire : ERNST & YOUNG AUDIT. Commissaire aux comptes suppléant : CARREGA (François). Ancien administrateur : POLICARD (Christian) Etablissement principal: Activité : fabrication de produits pharmaceutiques. Adresse : Z.I., La Ballastière, 33500 Libourne. Date d'effet : 23 décembre 2003.

12/11/2003

Bodacc B

Modifications et mutations diverses

RCS Libourne B 301763405 RC 89-B 43 CEVA SANTE ANIMALE. Forme : S.A. à conseil d'administration. Capital : 40 331 892 euros. Adresse du siège social : Z.I., La Ballastière, 33500 Libourne. Administration : P.-D.G. : DU MESNIL ( Philippe). Directeur général : LEBRETTE (Jean, Pierre, Christian). Administrateurs : EMERY (Bernard, Marie) DU MESNIL (Philippe) POLICARD ( Christian, Marie, Marcel) FINANCIERE MENDELSSOHN. Commissaire aux comptes titulaire : ERNST & YOUNG AUDIT. Commissaire aux comptes suppléant : CARREGA (François). Anciens administrateurs : COUFFIN (Hervé) TARANTO (Philippe) MOUTERDE (Patrick) DE MOUSTIER (Christilla) Etablissement principal: Activité : fabrication de produits pharmaceutiques. Adresse : Z.I., La Ballastière, 33500 Libourne. Date d'effet : 30 septembre 2003.

02/08/2002

Bodacc B

Modifications et mutations diverses

RCS Libourne B 301763405 RC 89-B 43 CEVA SANTE ANIMALE. Forme : S.A. à conseil d'administration. Capital : 40 331 892 euros. Adresse du siège social : Z.I., La Ballastière, 33500 Libourne. Administration : P.-D.G. : DU MESNIL ( Philippe). Directeur général : LEBRETTE (Jean, Pierre, Christian). Administrateurs : EMERY (Bernard, Marie) DU MESNIL (Philippe) TARANTO ( Philippe, Michel) COUFFIN (Hervé, Robert, Jean) POLICARD (Christian, Marie, Marcel) MOUTERDE (Patrick, Louis, Marie) M m e DE MOUSTIER, née DE ROUDNEFF (Christilla, Renée, Jeanne). Commissaire aux comptes titulaire : ERNST & YOUNG AUDIT. Commissaire aux comptes suppléant : CARREGA (François). Ancien président du conseil d' administration : DU MESNIL (Philippe) Etablissement principal: Activité : fabrication de produits pharmaceutiques. Adresse : Z.I., La Ballastière, 33500 Libourne. Date d'effet : 2 mai 2002.

15/05/2002

Bodacc B

Modifications et mutations diverses

RCS Libourne B 301763405 RC 89-B 43 CEVA SANTE ANIMALE. Forme : S.A. à conseil d'administration. Capital : 40 331 892 euros. Adresse du siège social : Z.I. La Ballastière, 33500 Libourne. Administration : président du conseil d' administration : DU MESNIL (Philippe). Directeur général : LEBRETTE (Jean, Pierre, Christian). Administrateurs : EMERY (Bernard, Marie) DU MESNIL ( Philippe) TARANTO (Philippe, Michel) COUFFIN (Hervé, Robert, Jean) POLICARD (Christian, Marie, Marcel) MOUTERDE (Patrick, Louis, Marie) M m e DE MOUSTIER, née DE ROUDNEFF ( Christilla, Renée, Jeanne). Commissaire aux comptes titulaire : ERNST & YOUNG AUDIT. Commissaire aux comptes suppléant : CARREGA (François). Ancien administrateur : RUDAUX (Hervé) Etablissement principal: Activité : fabrication de produits pharmaceutiques. Adresse : Z.I. La Ballastière, 33500 Libourne. Date d'effet : 3 avril 2002.

24/05/2001

Bodacc B

Modifications et mutations diverses

RCS Libourne B 301763405 RC 89-B 43 CEVA SANTE ANIMALE. Forme : S.A. à conseil d'administration. Capital : 40 331 892 euros. Adresse du siège social : Z.I., La Ballastière, 33500 Libourne. Administration : président du conseil d' administration et administrateur : DU MESNIL (Philippe). Directeur général : LEBRETTE (Jean, Pierre, Christian). Administrateurs : EMERY (Bernard, Marie) TARANTO (Philippe, Michel) RUDAUX ( Hervé, Philippe) COUFFIN (Hervé, Robert, Jean) POLICARD (Christian, Marie, Marcel) MOUTERDE (Patrick, Louis, Marie). Commissaire aux comptes titulaire : ERNST ET YOUNG AUDIT. Commissaire aux comptes suppléant : CARREGA (François). Ancien administrateur : FABRE (Jean, Marie) Etablissement principal: Activité : fabrication de produits pharmaceutiques. Adresse : Z.I., La Ballastière, 33500 Libourne. Date d'effet : 28 mars 2001.

02/08/2000

Bodacc B

Modifications et mutations diverses

RCS Libourne B 301763405 RC 89-B 43 CEVA SANTE ANIMALE. Forme : S.A. à conseil d'administration. Capital : 40 331 892 euros. Adresse du siège social : Z.I., La Ballastière, 33500 Libourne. Administration : président du conseil d' administration : DU MESNIL (Philippe). Directeur général : LEBRETTE (Jean, Pierre, Christian). Administrateurs : EMERY (Bernard, Marie) DU MESNIL ( Philippe) TARANTO (Philippe, Michel) FABRE (Jean-Marie, Christian) RUDAUX ( Hervé, Philippe) COUFFIN (Hervé, Robert, Jean). Nouvel administrateur : POLICARD (Christian, Marie, Marcel). Commissaire aux comptes titulaire : ERNST ET YOUNG AUDIT. Commissaire aux comptes suppléant : CARREGA (François) Etablissement principal: Activité : fabrication de produits pharmaceutiques. Adresse : Z.I., La Ballastière, 33500 Libourne. Date d'effet : 24 mai 2000.

25/07/2000

Bodacc A

Création d'établissement

RCS B 302 607 676 RC 74-B 05312 EUROLYSINE. Forme : S.A. Capital : 179 100 000 F. Activité : distribution des acides aminés. Adresse du siège social : 153 rue de Courcelles, 75017 Paris Branche d'activité acquise par achat, au prix stipulé de 13 500 000 F. Commentaires : branche d'activité sise zone industrielle de Libourne (33500) qui sera exploitée au 153 rue de Courcelles, 75017 Paris. Date d'effet : 1er avril 2000 Précédente propriétaire- exploitante CEVA SANTE ANIMALE 301 763 405. RCS Libourne. Publication légale: Les Echos judiciaires girondins du 10 mars 2000. Oppositions : au fonds.

16/04/2000

Bodacc B

Modifications et mutations diverses

RCS Libourne B 301763405 RC 89-B 43 CEVA SANTE ANIMALE. Forme : S.A. à conseil d'administration. Capital : 40 331 892 euros. Adresse du siège social : Z.I., La Ballastière, 33500 Libourne Etablissement principal: Adresse : Z.I., La Ballastière, 33500 Libourne ETABLISSEMENT PRINCIPAL nouvelle situation. Activité : fabrication de produits pharmaceutiques. Commentaires : cession de la branche d'activité afférente à la distribution des acides aminés. Date d'effet : 1er avril 2000.

28/03/2000

Bodacc A

Création d'établissement

RCS Paris B 302 607 676 SOCIETE EUROLYSINE. Forme : S.A. Capital : 179 100 000 F. Adresse du siège social : 153 rue de Courcelles, 75017 Paris Branche d' activité dépendant du fonds principal acquise par cession, au prix stipulé de 13 500 000 F Etablissement principal: Activité : distribution des acides aminés suivants L-Lysine, L-Thréonine et L-Tryptophane sous toute forme (ci- après les acides aminés). Adresse : La Ballastière, B.P. 126, 33500 Libourne. Date d'effet : 1er avril 2000 Précédente propriétaire-exploitante SOCIETE CEVA SANTE ANIMALE S.A. RCS Libourne B 301 763 405 Publication légale: Echos judiciaires girondins du 10 mars 2000. Oppositions : au siège social du cédant, Z.I. La Ballastière, 33500 Libourne, o domicile est élu.

30/01/2000

Bodacc B

Modifications et mutations diverses

Ancienne situation du siège social. RCS Libourne B 301763405 RC 89-B 43 SANOFI SANTE NUTRITION ANIMALE. Forme : S.A. à conseil d'administration. Capital : 40 331 892 euros. Adresse : Z.I., La Ballastière, 33500 Libourne Nouvelle situation du siège social dénomination: CEVA SANTE ANIMALE Etablissement principal: Activité : fabrication de produits pharmaceutiques. Adresse : Z.I., La Ballastière, 33500 Libourne. Date d'effet : 24 décembre 1999.

09/01/2000

Bodacc B

Modifications et mutations diverses

RCS Libourne B 301763405 RC 89-B 43 SANOFI SANTE NUTRITION ANIMALE. Forme : S. A. à conseil d'administration. Capital : 40 331 892 euros. Adresse du siège social : Z.I., La Ballastière, 33500 Libourne. Administration : président du conseil d'administration : DU MESNIL ( Philippe). Directeur général : LEBRETTE (Jean, Pierre, Christian). Administrateurs : EMERY (Bernard, Marie) DU MESNIL (Philippe) TARANTO ( Philippe, Michel) FABRE (Jean-Marie, Christian) RUDAUX (Hervé, Philippe) COUFFIN (Hervé, Robert, Jean). Commissaire aux comptes titulaire : ERNST ET YOUNG AUDIT. Commissaire aux comptes suppléant : CARREGA (François). Anciens administrateurs : POLICARD ( Christian) MORRE (Michel) SECIPE. Ancien président du conseil d' administration et administrateur : LEON (Jean, Paul) Etablissement principal: Activité : fabrication de produits pharmaceutiques. Adresse : Z.I., La Ballastière, 33500 Libourne. Date d'effet : 15 octobre 1999.

25/07/1999

Bodacc B

Modifications et mutations diverses

Ancienne situation du siège social. RCS Libourne B 301763405 RC 89-B 43 SANOFI- SANTE NUTRITION ANIMALE. Forme : S.A. à conseil d'administration. Capital : 263 952 175 F. Adresse : Z.I., La Ballastière, 33500 Libourne Nouvelle situation du siège social. Capital : 40 331 892 euros Etablissement principal: Activité : fabrication de produits pharmaceutiques. Adresse : Z.I., La Ballastière, 33500 Libourne. Commentaires : augmentation du capital et sa conversion en euros. Date d'effet : 15 avril 1999.

16/08/1996

Bodacc B

Modifications et mutations diverses

RCS o. RCS Libourne B 301 763 405 RC RC 89-B 43 SANOFI SANTE NUTRITION ANIMALE. Forme : S.A. à conseil d'administration. Capital : 263 952 175 F. Adresse du siège social : zone industrielle La Ballastière 33500 Libourne. Administration : président du conseil d' administration et administrateur : LEON (Jean-Paul) Directeur général administrateur : DU MESNIL (Philippe). Directeur général : LEBRETTE (Jean- Pierre, Christian). Administrateurs : SANOFI ELF BIO INDUSTRIES EMERY ( Bernard, Marie) POLICARD (Christian) MORRE (Michel, Christian, Louis). Commissaire aux comptes titulaire : ERNST ET YOUNG AUDIT. Commissaire aux comptes suppléant : CARREGA (François). Ancien président du conseil d' administration : POLICARD (Christian). Ancien administrateur : ARTIGUES (Paul) Etablissement principal: Activité : fabrication de produits pharmaceutiques. Adresse : zone industrielle La Ballastière 33500 Libourne Date de début d'activité: 30 décembre 1988. Date d'effet : 28 juin 1996.

16/06/1996

Bodacc B

Modifications et mutations diverses

Ancienne situation du siège social. RCS Libourne B 301 763 405 RC 89-B 43 SANOFI-SANTE NUTRITION ANIMALE. Forme : S. A. Capital : 87 406 600 F. Adresse : Z.I., La Ballastière 33500 Libourne Nouvelle situation du siège social. Capital : 263 952 175 F Etablissement principal: Activité : fabrication de produits pharmaceutiques. Adresse : Z.I., La Ballastière 33500 Libourne. Date d'effet : 20 mai 1996.

09/09/1995

Bodacc B

Modifications et mutations diverses

RCS Libourne B 301 763 405 RC 89-B 43 SANOFI-SANTE NUTRITION ANIMALE. Forme : S. A. Capital : 87 406 600 F. Adresse du siège social : Z.I. La Ballastière 33500 Libourne. Administration : président du conseil d'administration : POLICARD ( Christian). Directeur général et administrateur : DU MESNIL (Philippe). Directeur général : LEBRETTE (Jean, Pierre, Christian). Administrateurs : SANOFI ELF BIO INDUSTRIES EMERY ( Bernard, Marie) ARTIGUES (Paul) POLICARD (Christian). Nomination en qualité d'administrateur de MORRE ( Michel, Christian, Louis). Commissaire aux comptes titulaire : ERNST ET YOUNG AUDIT. Commissaire aux comptes suppléant : CARREGA (François). Ancien administrateur : REULET (Philippe) Etablissement principal: Activité : fabrication de produits pharmaceutiques. Adresse : Z.I. La Ballastière 33500 Libourne. Date d'effet : 25 avril 1995.

26/05/1995

Bodacc A

Création d'établissement

RCS Nanterre B 343 289 450 SANOFI DIAGNOSTICS PASTEUR. Forme : S.A. Capital : 96 440 100 F. Adresse du siège social : 3, boulevard Raymond-Poincaré, 92430 Marnes-la-Coquette. Administration : président-directeur général : PLICHON ( Bernard) Fonds principal acquis par achat au prix stipulé de : 6 000 000 de F Etablissement principal: Adresse : zone industrielle de la Ballastière, 33501 Libourne. Activité : recherche, développement, fabrication et commercialisation de trousses, diagnostic dans les domaines de la phytopathologie et vétérinaire. Date d'effet : 1er janvier 1995 Précédent propriétaire-exploitant SANOFI SANTE NUTRITION ANIMALE. RCS Libourne B 301 763 405 Publication légale: Le Courrier Français du Dimanche du 21 avril 1995. Oppositions : chez Me Bouchet, 125, rue du Président-Carnot, 33500 Libourne.

29/01/1995

Bodacc B

Modifications et mutations diverses

Ancienne situation du siège social. RCS Libourne B 301 763 405 RC 89-B 43 SANOFI SANTE NUTRITION ANIMALE. Forme : S. A. Capital : 100 000 000 de F. Adresse : Z. I., La Ballastière 33500 Libourne Nouvelle situation du siège social. Capital : 87 406 600 F Etablissement principal: Activité : fabrication de produits pharmaceutiques. Adresse : Z.I., La Ballastière 33500 Libourne. Commentaires : augmentation du capital de 36 406 600 F pour le porter de 51 000 000 de F à 87 406 600 F. Apport de la S.A. SANOFI à la S.S.N.A. évalué à 43 512 637 F. Date d'effet : 5 décembre 1994.

 

 

Synthesized Accounts

 

Annual Accounts

 

31/12/2012

31/12/2011

31/12/2010

Account period (month)

12

12

12

Account Type

Normal

Normal

Normal

Date of capture

31/10/2013

22/10/2013

03/08/2011

Activity Code

2120Z

2120Z

2120Z

Employees

0

0

753

 

 

Active account

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

SECTOR MEDIAN 2012

Capital not called

0

0%

0

0%

0

0

0%

Total fixed assets

390,248,000

14.9 %

339,752,000

10.2 %

308,439,000

2,374,610

16334.2 %

 Intangible assets

27,220,000

85.2 %

14,696,000

-8.7 %

16,102,000

153,273

17659.2 %

 Tangible assets

34,893,000

27.9 %

27,285,000

11.1 %

24,570,000

751,045

4545.9 %

 Financial assets

328,135,000

10.2 %

297,771,000

11.2 %

267,767,000

15,836

2071982.6 %

Net current assets

151,199,000

10.9 %

136,319,000

19.9 %

113,691,000

4,644,743

3155.3 %

 Stocks

32,196,000

10.9 %

29,019,000

15.4 %

25,157,000

1,133,446

2740.5 %

 Advanced payments

0

0%

0

0%

0

0

0%

 Receivables

79,298,000

-26.0 %

107,214,000

78.2 %

60,160,000

2,629,332

2915.9 %

 Securities and cash

39,705,000

46068.6 %

86,000

-99.7 %

28,374,000

340,567

11558.5 %

 Prepaid expenses

-

-

-

-

-

1,221

-

Accounts of regularization

2,839,000

-5.2 %

2,996,000

-42.9 %

5,250,000

0

0%

Total Assets

544,286,000

13.6 %

479,067,000

12.1 %

427,380,000

9,068,207

5902.1 %

 

Passive Account

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

SECTOR MEDIAN 2012

Shareholders' equity

195,568,000

15.5 %

169,275,000

12.4 %

150,601,000

2,671,507

7220.5 %

Share capital

40,332,000

0%

40,332,000

0%

40,332,000

522,500

7619.0 %

Other capital resources

2,178,000

70.0 %

1,281,000

4.6 %

1,225,000

0

0%

Risk Provisions

4,398,000

-0.4 %

4,414,000

-23.8 %

5,791,000

76,275

5666.0 %

Liabilities

336,095,000

10.5 %

304,097,000

14.3 %

265,953,000

4,523,794

7329.5 %

 Financial liabilities

213,896,000

14.9 %

186,198,000

4.2 %

178,777,000

378,896

56352.4 %

 Advanced payments received

41,084,000

0%

0

0%

0

0

0%

 Trade account payables

20,468,000

-43.9 %

36,469,000

3.7 %

35,162,000

1,396,545

1365.6 %

 Tax and social liabilities

6,375,000

-73.2 %

23,749,000

6.2 %

22,366,000

624,451

920.9 %

 Other debts and fixed assets liabilities

59,926,000

4.9 %

57,126,000

72.8 %

33,054,000

126,804

47158.8 %

Account regularization

393,000

-29.2 %

555,000

37.4 %

404,000

0

0%

Total liabilities

544,286,000

13.6 %

479,067,000

12.1 %

427,380,000

9,068,207

5902.1 %

 

Results

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

SECTOR MEDIAN 2012

Sales of Goods

286,742,000

5.8 %

270,954,000

9.7 %

247,098,000

10,171,095

2719.2 %

Net turnover

271,913,000

4.9 %

259,250,000

9.0 %

237,913,000

9,712,338

2699.7 %

 of which net export turnover

0

0%

0

0%

0

348,537

0%

Operating charges

248,750,000

9.0 %

228,311,000

10.0 %

207,561,000

9,344,775

2561.9 %

Operating profit/loss

37,992,000

-10.9 %

42,643,000

7.9 %

39,537,000

224,351

16834.2 %

Financial income

26,000,000

11.8 %

23,262,000

-17.3 %

28,114,000

10,905

238333.7 %

Financial charges

22,923,000

-4.1 %

23,900,000

23.7 %

19,324,000

40,713

56203.9 %

Financial profit/loss

3,077,000

582.3 %

-638,000

-107.3 %

8,790,000

-696

442515.5 %

Pretax net operating income

41,069,000

-2.2 %

42,005,000

-13.1 %

48,327,000

189,296

21595.7 %

Extraordinary income

902,000

-55.6 %

2,030,000

320.3 %

483,000

19,628

4495.6 %

Extraordinary charges

1,024,000

-54.7 %

2,258,000

87.4 %

1,205,000

35,450

2788.6 %

Extraordinary profit/loss

-122,000

46.5 %

-228,000

68.4 %

-722,000

0

0%

Net result

31,930,000

31.0 %

24,369,000

-28.1 %

33,915,000

152,838

20791.5 %

 

 

Accounts – Active

 

Normal Account

 

31/12/2012

31/12/2011

31/12/2010

Months

12

12

12

 

Grand Total - Active Accounts (I to VI)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Grand Total (I to VI)

Net

544,286,000

13.6 %

479,067,000

12.1 %

427,380,000

Gross

CO

627,088,000

13.9 %

550,680,000

13.8 %

483,963,000

Amortisation

1A

82,802,000

15.6 %

71,613,000

26.6 %

56,583,000

 

Non declared distributed capital (I)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Non declared distributed capital (I)

AA3

0

0%

0

0%

0

Gross

AA

0

0%

0

0%

0

 

Active fixed asset (II)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Total Active fixed asset (II)

Net

390,248,000

14.9 %

339,752,000

10.2 %

308,439,000

Gross

BJ

471,007,000

15.0 %

409,573,000

12.2 %

365,022,000

Amortisation

BK

80,759,000

15.7 %

69,821,000

23.4 %

56,583,000

 

Intangible fixed assets

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Start-up cost

Net

0

0%

0

0%

0

Gross

AB

0

0%

0

0%

0

Amortisation

AC

0

0%

0

0%

0

R&D expenses

Net

0

0%

0

0%

0

Gross

CX

0

0%

0

0%

0

Amortisation

AE

0

0%

0

0%

0

Distributorships, patents

Net

0

0%

6,979,000

-13.0 %

8,025,000

Gross

AF

0

0%

26,969,000

10.3 %

24,451,000

Amortisation

AG

0

0%

19,990,000

21.7 %

16,426,000

Goodwill

Net

0

0%

2,853,000

0%

2,853,000

Gross

AH

0

0%

2,853,000

0%

2,853,000

Amortisation

AI

0

0%

0

0%

0

Other intangible fixed assets

Net

27,220,000

459.6 %

4,864,000

-6.9 %

5,224,000

Gross

AJ

50,900,000

946.5 %

4,864,000

-6.9 %

5,224,000

Amortisation

AK

23,680,000

0%

0

0%

0

Pre-payments and downpayments

Net

0

0%

0

0%

0

Gross

AL

0

0%

0

0%

0

Amortisation

AM

0

0%

0

0%

0

Sub Total Intangible asset

Net

27,220,000

85.2 %

14,696,000

-8.7 %

16,102,000

 

Tangilble fixed assets

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Lands

Net

2,548,000

15.5 %

2,206,000

0%

2,206,000

Gross

AN

2,548,000

15.5 %

2,206,000

0%

2,206,000

Amortisation

AO

0

0%

0

0%

0

Buildings

Net

11,405,000

16.5 %

9,787,000

-7.1 %

10,536,000

Gross

AP

26,994,000

11.3 %

24,248,000

1.0 %

24,016,000

Amortisation

AQ

15,589,000

7.8 %

14,461,000

7.3 %

13,480,000

Plant

Net

11,713,000

33.8 %

8,753,000

-10.2 %

9,748,000

Gross

AR

25,701,000

23.0 %

20,902,000

2.8 %

20,341,000

Amortisation

AS

13,988,000

15.1 %

12,149,000

14.7 %

10,593,000

Other tangible fixed assets

Net

495,000

-13.5 %

572,000

-11.7 %

648,000

Gross

AT

1,976,000

0.2 %

1,973,000

3.1 %

1,913,000

Amortisation

AU

1,481,000

5.7 %

1,401,000

10.8 %

1,265,000

Fixed assets in construction

Net

8,732,000

46.3 %

5,967,000

316.7 %

1,432,000

Gross

AV

8,732,000

46.3 %

5,967,000

316.7 %

1,432,000

Amortisation

AW

0

0%

0

0%

0

Advances and payments on account

Net

0

0%

0

0%

0

Gross

AX

0

0%

0

0%

0

Amortisation

AY

0

0%

0

0%

0

Sub Total Tangible asset

Net

34,893,000

27.9 %

27,285,000

11.1 %

24,570,000

 

Financial assets

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Associates at equity

Net

0

0%

0

0%

0

Gross

CS

0

0%

0

0%

0

Amortisation

CT

0

0%

0

0%

0

Other participations

Net

152,500,000

18.1 %

129,178,000

8.9 %

118,647,000

Gross

CU

175,637,000

17.9 %

148,997,000

13.2 %

131,642,000

Amortisation

CV

23,137,000

16.7 %

19,819,000

52.5 %

12,995,000

Inter-company receivables

Net

175,397,000

4.1 %

168,500,000

13.1 %

149,028,000

Gross

BB

178,191,000

4.6 %

170,411,000

13.1 %

150,672,000

Amortisation

BC

2,794,000

46.2 %

1,911,000

16.2 %

1,644,000

Other investment securities

Net

0

0%

0

0%

0

Gross

BD

0

0%

0

0%

0

Amortisation

BE

0

0%

0

0%

0

Loans

Net

0

0%

0

0%

0

Gross

BF

0

0%

0

0%

0

Amortisation

BG

0

0%

0

0%

0

Other financial assets

Net

238,000

155.9 %

93,000

1.1 %

92,000

Gross

BH

328,000

79.2 %

183,000

-32.7 %

272,000

Amortisation

BI

90,000

0%

90,000

-50.0 %

180,000

Sub Total Financial assets

Net

328,135,000

10.2 %

297,771,000

11.2 %

267,767,000

 

Current Assets (III)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Total Assets

Net

151,199,000

10.9 %

136,319,000

19.9 %

113,691,000

Gross

CJ

153,242,000

11.0 %

138,111,000

21.5 %

113,691,000

Amortisation

CK

2,043,000

14.0 %

1,792,000

0%

0

 

Stocks

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Raw materials

Net

0

0%

29,019,000

0%

0

Gross

BL

0

0%

29,990,000

0%

0

Amortisation

BM

0

0%

971,000

0%

0

Work in progress (goods)

Net

0

0%

0

0%

0

Gross

BN

0

0%

0

0%

0

Amortisation

BO

0

0%

0

0%

0

Work in progress (services)

Net

0

0%

0

0%

0

Gross

BP

0

0%

0

0%

0

Amortisation

BQ

0

0%

0

0%

0

Semi-finished and finished products

Net

0

0%

0

0%

0

Gross

BR

0

0%

0

0%

0

Amortisation

BS

0

0%

0

0%

0

Goods for resale

Net

32,196,000

0%

0

0%

25,157,000

Gross

BT

33,478,000

0%

0

0%

25,157,000

Amortisation

BU

1,282,000

0%

0

0%

0

Sub Total Stocks

Net

32,196,000

10.9 %

29,019,000

15.4 %

25,157,000

 

Advance payments to suppliers

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Advance payments to suppliers

Net

0

0%

0

0%

0

Gross

BV

0

0%

0

0%

0

Amortisation

BW

0

0%

0

0%

0

 

Debtors

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Trade accounts receivable

Net

59,499,000

8.3 %

54,928,000

6.0 %

51,814,000

Gross

BX

60,217,000

8.0 %

55,749,000

7.6 %

51,814,000

Amortisation

BY

718,000

-12.5 %

821,000

0%

0

Other debtors

Net

18,380,000

-64.5 %

51,770,000

559.6 %

7,849,000

Gross

BZ

18,423,000

-64.4 %

51,770,000

559.6 %

7,849,000

Amortisation

CA

43,000

0%

0

0%

0

Capital subscribed and called up

Net

0

0%

0

0%

0

Gross

CB

0

0%

0

0%

0

Amortisation

CC

0

0%

0

0%

0

Sub Total debtors

Net

77,879,000

-27.0 %

106,698,000

78.8 %

59,663,000

 

Divers

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Investment securities

Net

37,882,000

0%

0

0%

25,525,000

Gross

CD

37,882,000

0%

0

0%

25,525,000

Amortisation

CE

0

0%

0

0%

0

Cash and cash equivalents

Net

1,823,000

2019.8 %

86,000

-97.0 %

2,849,000

Gross

CF

1,823,000

2019.8 %

86,000

-97.0 %

2,849,000

Amortisation

CG

0

0%

0

0%

0

Sub Total Divers

Net

39,705,000

46068.6 %

86,000

-99.7 %

28,374,000

 

Prepaid expenses

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Prepaid expenses

Net

1,419,000

175.0 %

516,000

3.8 %

497,000

Gross

CH

1,419,000

175.0 %

516,000

3.8 %

497,000

Amortisation

CI

0

0%

0

0%

0

 

Equalization accounts (IV to VI)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Multi-period charges

CW3

551,000

-34.3 %

839,000

-25.6 %

1,127,000

Gross

551,000

-34.3 %

839,000

-25.6 %

1,127,000

Premiums on redemption of bonds

CM3

0

0%

0

0%

0

Gross

0

0%

0

0%

0

Currency differential gain

CN3

2,288,000

6.1 %

2,157,000

-47.7 %

4,123,000

Gross

2,288,000

6.1 %

2,157,000

-47.7 %

4,123,000

 

References

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Due within one year

CP

0

0%

0

0%

0

Due after one year

CR

0

0%

0

0%

0

 

 

Accounts – Passive

 

Grand Total - Passive Accounts (I to V)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Grand Total (I to V)

EE

544,286,000

13.6 %

479,067,000

12.1 %

427,380,000

 

Shareholder Equity (I)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Total shareholders' equity (Total I)

DL

195,568,000

15.5 %

169,275,000

12.4 %

150,601,000

Equity and shareholders' equity

DA

40,332,000

0%

40,332,000

0%

40,332,000

Issue and merger premiums

DB

0

0%

0

0%

0

Revaluation differentials

DC

0

0%

0

0%

0

Of which equity differential

EK

0

0%

0

0%

0

Legal reserve

DD

4,033,000

0%

4,033,000

0%

4,033,000

Statutory or contractual reserve

DE

0

0%

0

0%

0

Special regulated reserves

DF

1,028,000

0%

1,028,000

0%

1,028,000

Of which special reserve of provisions for current fluctuation

B1

0

0%

0

0%

0

Other reserves

DG

0

0%

0

0%

0

Of which reserve for buying originals works from alive artists

EJ

0

0%

0

0%

0

Profits or losses brought forward

DH

114,906,000

19.1 %

96,450,000

40.9 %

68,447,000

Profit or loss for the period

DI

31,930,000

31.0 %

24,369,000

-28.1 %

33,915,000

Investment grants

DJ

483,000

-12.3 %

551,000

-11.0 %

619,000

Special tax-allowable reserves

DK

2,856,000

13.7 %

2,512,000

12.8 %

2,227,000

 

Other capital resources (II)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Total other capital resources (Total II)

DO

2,178,000

70.0 %

1,281,000

4.6 %

1,225,000

Income from participating securities

DM

0

0%

0

0%

0

Conditional loans

DN

2,178,000

70.0 %

1,281,000

4.6 %

1,225,000

 

Provisions for risks and charges (III)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Total provisions for risks and charges (Total III)

DR

4,398,000

-0.4 %

4,414,000

-23.8 %

5,791,000

Risk provisions

DP

4,398,000

-0.4 %

4,414,000

0%

0

Reserves for charges

DQ

0

0%

0

0%

5,791,000

 

Liabilities (IV)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Total Liabilities (Total IV)

EC

336,095,000

10.5 %

304,097,000

14.3 %

265,953,000

Convertible debentures

DS

0

0%

0

0%

0

Other debentures

DT

0

0%

0

0%

0

Bank loans and liabilities

DU

98,405,000

-7.3 %

106,198,000

8.6 %

97,817,000

Sundry loans and financial liabilities

DV

115,491,000

44.4 %

80,000,000

-1.2 %

80,960,000

Of which participating loans

EI

0

0%

0

0%

0

Advance payments received for current orders

DW

41,084,000

0%

0

0%

0

Trade accounts payables

DX

20,468,000

-43.9 %

36,469,000

3.7 %

35,162,000

Tax and social security liabilities

DY

6,375,000

-73.2 %

23,749,000

6.2 %

22,366,000

Fixed asset liabilities

DZ

19,875,000

445.6 %

3,643,000

39.7 %

2,608,000

Other debts

EA

34,004,000

-36.4 %

53,483,000

100.8 %

26,636,000

 

Translation loss (V)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Translation loss (Total V)

ED

6,047,000

0%

0

0%

3,810,000

 

Equalization accounts

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Deferred income

EB

393,000

-29.2 %

555,000

37.4 %

404,000

 

References

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Of which tax-allowable reserve

EF

0

0%

0

0%

0

Deferred income and liabilities

EG

0

0%

0

0%

0

Of which current bank facilities

EH

0

0%

0

0%

0

 

 

Result account

 

1 - Operating result (I-II)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Operating result (Total I-II)

GG

37,992,000

-10.9 %

42,643,000

7.9 %

39,537,000

 

2 - Financial result (V-VI)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Financial result (Total V-VI)

GV

3,077,000

582.3 %

-638,000

-107.3 %

8,790,000

 

3 - Pre-tax net operating income result (I to VI)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Pre-tax net operating income (Total I-II+II-IV+V-VI)

GW

41,069,000

-2.2 %

42,005,000

-13.1 %

48,327,000

 

4 - Extraordinary result (VII-VIII)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Extraordinary result (Total VII-VIII)

HI

-122,000

46.5 %

-228,000

68.4 %

-722,000

 

Profit or loss

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Profit or loss

HN

31,930,000

31.0 %

24,369,000

-28.1 %

33,915,000

 

Total Income (I+III+V+VII)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Total Income (Total I+III+V+VII)

HL

313,644,000

5.9 %

296,246,000

7.5 %

275,695,000

 

Total Charges (Total II+IV+VI+VIII+IX+X)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Total Charges (Total II+IV+VI+VIII+IX+X)

HM

281,714,000

3.6 %

271,877,000

12.4 %

241,780,000

 

Operating income (I)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Total operating income (Total I)

FR

286,742,000

5.8 %

270,954,000

9.7 %

247,098,000

 

Operating income (details)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Sale of goods for resale

FC

271,913,000

0%

0

0%

0

France

FA

271,913,000

0%

0

0%

0

Export

FB

0

0%

0

0%

0

Sale of goods produced

FF

0

0%

259,250,000

9.0 %

237,913,000

France

FD

0

0%

259,250,000

9.0 %

237,913,000

Export

FE

0

0%

0

0%

0

Sale of services

FI

0

0%

0

0%

0

France

FG

0

0%

0

0%

0

Export

FH

0

0%

0

0%

0

Net turnover

FL

271,913,000

4.9 %

259,250,000

9.0 %

237,913,000

France

FJ

271,913,000

4.9 %

259,250,000

9.0 %

237,913,000

Export

FK

0

0%

0

0%

0

Stocked production

FM

2,620,000

4.8 %

2,499,000

20725.0 %

12,000

Self-constructed assets

FN

0

0%

0

0%

0

Operating grants

FO

0

0%

0

0%

0

Release of reserves and provisions

FP

3,392,000

78.0 %

1,906,000

-41.9 %

3,278,000

Other income

FQ

8,817,000

20.8 %

7,299,000

23.8 %

5,895,000

 

Operating charges (II)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Total operating charges (Total II)

GF

248,750,000

9.0 %

228,311,000

10.0 %

207,561,000

 

Exploitation charges

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Purchase of goods for resale

FS

93,460,000

0%

0

0%

0

Change in stocks of goods for resale

FT

-868,000

0%

0

0%

0

Purchase of raw materials

FU

0

0%

91,394,000

6.0 %

86,199,000

Change in stocks of raw materials

FV

0

0%

-1,032,000

46.2 %

-1,919,000

Other external purchases and charges

FW

88,078,000

17.8 %

74,743,000

15.6 %

64,683,000

Tax, duty and similar payments

FX

6,090,000

-7.6 %

6,589,000

62.7 %

4,050,000

Payroll

FY

34,089,000

9.5 %

31,118,000

4.8 %

29,680,000

Social security costs

FZ

16,963,000

9.5 %

15,492,000

11.0 %

13,952,000

 

Depreciation

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Depreciation of fixed assets

GA

7,840,000

4.9 %

7,471,000

26.0 %

5,929,000

Amortisation of fixed assets

GB

0

0%

0

0%

0

Depreciation/amortisation of current assets

GC

933,000

49.3 %

625,000

-46.4 %

1,166,000

Provisions for risks and charges

GD

979,000

6.5 %

919,000

-26.9 %

1,257,000

 

Other charges

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Other charges

GE

1,186,000

19.6 %

992,000

-61.3 %

2,564,000

 

Operating charges (III-IV)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Share of joint-venture transferred to other partner(s) (Total III)

GH

0

0%

0

0%

0

Share of joint venture transferred from other partner(s) (Total IV)

GI

0

0%

0

0%

0

 

Financial income (V)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Total financial income (Total V)

GP

26,000,000

11.8 %

23,262,000

-17.3 %

28,114,000

Share financial income

GJ

0

0%

8,358,000

0%

0

Other investment income & capitalised receivables

GK

0

0%

0

0%

0

Other interest and similar income

GL

26,000,000

235.7 %

7,745,000

-72.5 %

28,114,000

Released provisions and transferred charges

GM

0

0%

4,664,000

0%

0

Exchange gains

GN

0

0%

2,495,000

0%

0

Net income from disposal of investment securities

GO

0

0%

0

0%

0

 

Financial charge (VI)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Total financial charge (Total VI)

GU

22,923,000

-4.1 %

23,900,000

23.7 %

19,324,000

Financial reserves and provisions

GQ

0

0%

9,699,000

0%

0

Interest and similar charges

GR

22,923,000

99.0 %

11,519,000

-40.4 %

19,324,000

Exchange losses

GS

0

0%

2,682,000

0%

0

Net loss from disposal of investment securities

GT

0

0%

0

0%

0

 

Extraordinary income (VII)

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Total extraordinary income (Total VII)

HD

902,000

-55.6 %

2,030,000

320.3 %

483,000

Extraordinary operating income

HA

0

0%

261,000

27.3 %

205,000

Extraordinary income from capital transactions

HB

902,000

-35.3 %

1,394,000

1202.8 %

107,000

Released provisions and transferred charges

HC

0

0%

375,000

119.3 %

171,000

 

Extraordinary charges (VIII)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Total extraordinary charges (Total VIII)

HH

1,024,000

-54.7 %

2,258,000

87.4 %

1,205,000

Extraordinary operating charges

HE

0

0%

129,000

2050.0 %

6,000

Extraordinary charges from capital transactions

HF

1,024,000

-30.2 %

1,468,000

354.5 %

323,000

Extraordinary reserves and provisions

HG

0

0%

661,000

-24.5 %

876,000

 

Employee profit sharing (IX)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Employee profit sharing (Total IX)

HJ

3,882,000

-34.2 %

5,901,000

73.6 %

3,399,000

 

Tax on profits (X)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Tax on profits (Total X)

HK

5,135,000

-55.4 %

11,507,000

11.8 %

10,291,000

 

References

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Of which equipment leases

HP

0

0%

0

0%

0

Of which property leases

HQ

0

0%

0

0%

0

Of which transferred charges

A1

0

0%

0

0%

0

Of which trader's own contributions

A2

0

0%

0

0%

0

Of which royalties on licences and patents (income)

A3

0

0%

0

0%

0

Of which royalties on licences and patents (charges)

A4

0

0%

0

0%

0

 

 

 

Other incomes tax return forms

 

Fixed Assets

 

Grand Total Fixed Assets (I to IV)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Gross value at begin of period

OG

0

0%

0

0%

0

Increasess due to revaluation

OH

0

0%

0

0%

0

Decreasess, acquisitions, creations, contributions

OJ

0

0%

0

0%

0

Decreasess by budget item transfer

OK1

0

0%

0

0%

0

Decreasess by transfers

OK2

0

0%

0

0%

13,559,000

Gross value at the end of period

OL

0

0%

0

0%

365,022,000

 

Research and development Charge (Total I)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Gross value at begin of period

CZ

0

0%

0

0%

0

Increasess due to revaluation

KB

0

0%

0

0%

0

Increasess, acquisitions, creations, contributions

KC

0

0%

0

0%

0

Decreasess by budget item transfer

CO1

0

0%

0

0%

0

Decreasess by transfers

CO2

0

0%

0

0%

0

Gross value at the end of period

DO

0

0%

0

0%

0

 

Other budget item from Intangible fixed assets (Total II)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Gross value at begin of period

KD

0

0%

0

0%

30,339,000

Increasess due to revaluation

KE

0

0%

0

0%

0

Increasess, acquisitions, creations, contributions

KF

0

0%

0

0%

2,732,000

Decreasess by budget item transfer

LV1

0

0%

0

0%

51,000

Decreasess by transfers

LV2

0

0%

0

0%

492,000

Gross value at the end of period

LW

0

0%

0

0%

32,528,000

 

Tangible fixed assets (Total III)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Gross value at begin of period

LN

0

0%

0

0%

42,382,000

Increasess due to revaluation

LO

0

0%

0

0%

0

Increasess, acquisitions, creations, contributions

LP

0

0%

0

0%

7,770,000

Decreasess by budget item transfer

NG1

0

0%

0

0%

-51,000

Decreasess by transfers

NG2

0

0%

0

0%

295,000

Gross value at the end of period

NH

0

0%

0

0%

49,908,000

 

Financial assets (Total IV)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Gross value at begin of period

LQ

0

0%

0

0%

202,652,000

Increasess due to revaluation

LR

0

0%

0

0%

0

Increasess, acquisitions, creations, contributions

LS

0

0%

0

0%

92,706,000

Decreasess by budget item transfer

NJ1

0

0%

0

0%

0

Decreasess by transfers

NJ2

0

0%

0

0%

12,772,000

Gross value at the end of period

NK

0

0%

0

0%

282,586,000

Reserve for depreciation

 

Situation and movement of reserve for depreciation - Grand total (I-II-III)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Reserve for depreciation value at begin of period

ON

0

0%

0

0%

0

Increases

OP

0

0%

0

0%

0

Decreasess

OQ

0

0%

0

0%

0

Reserve for depreciation value at the end of period

OR

0

0%

0

0%

0

 

Research and development charge (Total I)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Reserve for depreciation value at begin of period

CY

0

0%

0

0%

0

Increases

PB

0

0%

0

0%

0

Decreasess

PC

0

0%

0

0%

0

Decreasess by budget item transfer

PD

0

0%

0

0%

0

 

Other intangible assets (Total II)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Reserve for depreciation value at begin of period

PE

0

0%

0

0%

13,906,000

Increases

PF

0

0%

0

0%

3,069,000

Decreasess

PG

0

0%

0

0%

549,000

Decreasess by budget item transfer

PH

0

0%

0

0%

16,426,000

 

Total fixed assets amotisation (Total III)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Reserve for depreciation value at begin of period

QU

0

0%

0

0%

23,009,000

Increases

QV

0

0%

0

0%

2,572,000

Decreases

QW

0

0%

0

0%

243,000

Decreasess by budget item transfer

QX

0

0%

0

0%

25,338,000

 

 

Movements during period affecting charge allocated over several period

 

Deferred charges and debt issuance costs

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Gross value at begin of period

Z91

0

0%

0

0%

0

Increases

Z92

0

0%

0

0%

0

Depreciation of fixed assets during period

Z9

0

0%

0

0%

0

Decreasess by budget item transfer

B1

0

0%

0

0%

0

 

Premium refund of obligations

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Net value at begin of period

SP1

0

0%

0

0%

0

Increases

SP2

0

0%

0

0%

0

Depreciation of fixed assets during period

SP

0

0%

0

0%

0

Net value at the end of period

SR

0

0%

0

0%

0

 

 

Provisions included in balance sheet

 

Grand Total (I-II-III)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Value at begining of period

7C

0

0%

0

0%

28,952,000

Increases

UB

0

0%

0

0%

11,273,000

Decreases

UC

0

0%

0

0%

13,907,000

Value at the end of period

UD

0

0%

0

0%

26,318,000

 

Includes Total allocations

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Operating

UE

0

0%

0

0%

0

Financial

UG

0

0%

0

0%

0

Exceptional

UJ

0

0%

0

0%

0

 

Includes Total Withdrawal

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Operating

UF

0

0%

0

0%

0

Financial

UH

0

0%

0

0%

0

Exceptional

UK

0

0%

0

0%

0

 

Total regulated provisions (Total I)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Value at begining of period

3Z

0

0%

0

0%

1,523,000

Increases

TS

0

0%

0

0%

875,000

Decreases

TT

0

0%

0

0%

171,000

Value at the end of period

TU

0

0%

0

0%

2,227,000

 

Total risk and charge provisions (Total II)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Value at begining of period

5Z

0

0%

0

0%

6,580,000

Increases

TV

0

0%

0

0%

5,379,000

Decreases

TW

0

0%

0

0%

6,168,000

Value at the end of period

TX

0

0%

0

0%

5,791,000

 

Total Provision for depreciation (Total III)

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Value at begining of period

7B

0

0%

0

0%

20,849,000

Increases

TY

0

0%

0

0%

5,019,000

Decreases

TZ

0

0%

0

0%

7,568,000

Value at the end of period

UA

0

0%

0

0%

18,300,000

 

 

State deadlines claims and debts at the end of period

 

State claims

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Gross value

VT

0

0%

0

0%

211,442,000

1 year at most

VU

0

0%

0

0%

74,954,000

More than one year

VV

0

0%

0

0%

136,488,000

 

State of loans

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Claims related to holdings (gross)

UL

0

0%

0

0%

150,672,000

Claims related to shareholdings (1 year at most)

UM

0

0%

0

0%

14,184,000

Loans (gross)

UP

0

0%

0

0%

2,000

Loans (1 year at most)

UR

0

0%

0

0%

2,000

Other financial assets (gross)

UT

0

0%

0

0%

270,000

Other financial assets (1 year at most)

UV

0

0%

0

0%

270,000

 

Receivables statement of assets

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Customers doubtful or disputed

VA

0

0%

0

0%

0

Other claims customer

UX

0

0%

0

0%

52,649,000

Receivables represent Loaned Securities

UU

0

0%

0

0%

0

Provision for depreciation previously established

UQ

0

0%

0

0%

0

Personnel and associated accounts

UY

0

0%

0

0%

0

Social Security and other social organizations

UZ

0

0%

0

0%

0

Income taxes

VM

0

0%

0

0%

0

Value added tax

VB

0

0%

0

0%

0

Other taxes and payments assimilated

VN

0

0%

0

0%

0

State and other public - Miscellaneous

VP

0

0%

0

0%

0

Group and Associates

VC

0

0%

0

0%

0

Accounts receivable (including claims relating to the operation of pension titles)

VR

0

0%

0

0%

7,849,000

 

Prepaid

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Prepaid

VS

0

0%

0

0%

0

 

State Debt

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Total debt (gross)

VY

0

0%

0

0%

265,549,000

1 year at most

VZ2

0

0%

0

0%

100,587,000

More than 1 year and 5 years at most

VZ3

0

0%

0

0%

164,962,000

More than 5 years

VZ4

0

0%

0

0%

0

 

Details

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Convertible bonds (gross)

7Y1

0

0%

0

0%

0

1 year at most

7Y2

0

0%

0

0%

0

More than 1 year and 5 years at most

7Y3

0

0%

0

0%

0

Other bonds (gross)

7Z1

0

0%

0

0%

0

1 year at most

7Z2

0

0%

0

0%

0

More than 1 year and 5 years at most

7Z3

0

0%

0

0%

0

Borrowing & debts to 1 year maximum at the origin (gross)

VG1

0

0%

0

0%

0

1 year at most

VG2

0

0%

0

0%

0

More than 1 year and 5 years at most

VG3

0

0%

0

0%

0

Borrowing & debts to more than 1 year at the origin (gross)

VH1

0

0%

0

0%

97,817,000

1 year at most

VH2

0

0%

0

0%

13,610,000

More than 1 year and 5 years at most

VH3

0

0%

0

0%

84,207,000

Loans and various financial liabilities (gross)

8A1

0

0%

0

0%

80,960,000

1 year at most

8A2

0

0%

0

0%

205,000

More than 1 year and 5 years at most

8A3

0

0%

0

0%

80,755,000

Suppliers and associated accounts (gross)

8B1

0

0%

0

0%

35,162,000

1 year at most

8B2

0

0%

0

0%

35,162,000

More than 1 year and 5 years at most

8B3

0

0%

0

0%

35,162,000

Personnel and associated accounts (gross)

8C1

0

0%

0

0%

13,139,000

1 year at most

8C2

0

0%

0

0%

13,139,000

More than 1 year and 5 years at most

8C3

0

0%

0

0%

0

Social Security and other social organizations (gross)

8D1

0

0%

0

0%

3,605,000

1 year at most

8D2

0

0%

0

0%

3,605,000

More than 1 year and 5 years at most

8D3

0

0%

0

0%

0

Taxes on profits (gross)

8E1

0

0%

0

0%

0

1 year at most

8E2

0

0%

0

0%

0

More than 1 year and 5 years at most

8E3

0

0%

0

0%

0

VAT (Gross)

VW1

0

0%

0

0%

0

1 year at most

VW2

0

0%

0

0%

0

More than 1 year and 5 years at most

VW3

0

0%

0

0%

0

Backed Obligations (gross)

VX1

0

0%

0

0%

0

1 year at most

VX2

0

0%

0

0%

0

More than 1 year and 5 years at most

VX3

0

0%

0

0%

0

Other taxes and assimilated (gross)

VQ1

0

0%

0

0%

5,622,000

1 year at most

VQ2

0

0%

0

0%

5,622,000

More than 1 year and 5 years at most

VQ3

0

0%

0

0%

0

Assets and liabilities associated accounts (gross)

8J1

0

0%

0

0%

2,608,000

1 year at most

8J2

0

0%

0

0%

2,608,000

More than 1 year and 5 years at most

8J3

0

0%

0

0%

0

More than 5 years

8J4

0

0%

0

0%

0

Groups and associates (gross)

VI1

0

0%

0

0%

0

1 year at most

VI2

0

0%

0

0%

0

More than 1 year and 5 years at most

VI3

0

0%

0

0%

0

More than 5 years

V14

0

0%

0

0%

0

Other liabilities (gross)

8K1

0

0%

0

0%

26,636,000

1 year at most

8K2

0

0%

0

0%

26,636,000

More than 1 year and 5 years at most

8K3

0

0%

0

0%

0

Debt representative of borrowed securities (gross)

SZ1

0

0%

0

0%

0

1 year at most

SZ2

0

0%

0

0%

0

More than 1 year and 5 years at most

SZ3

0

0%

0

0%

0

Products in advance (gross)

8L1

0

0%

0

0%

0

1 year at most

8L2

0

0%

0

0%

0

More than 1 year and 5 years at most

8L3

0

0%

0

0%

0

 

References

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Loans made during the period

VJ

0

0%

0

0%

0

Debt repaid during the period

VK

0

0%

0

0%

0

 

 

 

Table allocation results and other information

 

Dividends distributed

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Dividends

ZE

0

0%

0

0%

0

 

Commitments

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Commitments leasing furniture

YQ

0

0%

0

0%

0

Commitments Real Estate Leasing

YR

0

0%

0

0%

0

Effects brought to the discount and unmatured

YS

0

0%

0

0%

0

 

Other charges Externes

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Subcontracting

YT

0

0%

0

0%

0

Rentals, rental charges and condominiums

XQ

0

0%

0

0%

0

Staff outside the company

YU

0

0%

0

0%

0

Remuneration intermediaries and fees (excluding fees)

SS

0

0%

0

0%

0

Fees, commissions and brokerage

YV

0

0%

0

0%

0

Other accounts

ST

0

0%

0

0%

0

Total Other purchases and external

ZJ

0

0%

0

0%

0

 

Taxes and Fees

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Business tax

YW

0

0%

0

0%

0

Other taxes and payments assimilated

9Z

0

0%

0

0%

0

Total taxes and fees

YX

0

0%

0

0%

0

 

VAT

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Amount VAT collected

YY

0

0%

0

0%

0

Total VAT on goods and services

YZ

0

0%

0

0%

0

 

Average number of employees

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Average number of employees

YP

0

0%

0

0%

753

 

Groups and Shareholders

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

Groups and Shareholders

ZR

-

-

-

-

-

 

 

Ratios

 

Structure and Liquidity

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

SECTOR MEDIAN 2012

Fixed Asset Financing

1.05

0%

1.05

-2.8 %

1.08

1.42

-26.1 %

Global Debt

445 days

5.5 %

422 days

5.0 %

402 days

153 days

190.8 %

Working Capital Fund overall net

34 days

13.3 %

30 days

-28.6 %

42 days

88 days

-61.4 %

Financial independence

91.43 %

0.6 %

90.91 %

7.9 %

84.24 %

310.83 %

-70.6 %

Solvability

36.33 %

2.1 %

35.60 %

0.2 %

35.52 %

44.34 %

-18.1 %

Capacity debt futures

-

-

-

-

1,106.55 %

3,334.03 %

-

Coverage of current assets by net working capital overall

13.60 %

-12.6 %

15.56 %

-22.8 %

20.15 %

44.17 %

-69.2 %

General Liquidity

-

-

-

-

0.75

0.77

-

Restricted Liquidity

-

-

-

-

1.03

1.01

-

 

Management or rotation

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

SECTOR MEDIAN 2012

Need background in operating working capital

-16 days

-161.5 %

26 days

966.7 %

-3 days

54 days

-129.6 %

Treasury

53 days

0%

0 days

0%

43 days

13 days

307.7 %

Inventory turnover of goods

130 days

-

-

-

-

38 days

242.1 %

Average length of credit granted to customers

80 days

3.9 %

77 days

-1.3 %

78 days

68 days

17.6 %

Average length of credit obtained suppliers

41 days

-48.8 %

80 days

-5.9 %

85 days

81 days

-49.1 %

Inventory turnover of raw materials in industrial enterprises

-

-

118 days

0%

0 days

91 days

-

Inventory turnover of intermediate and finished products in the industrial enterprise

-

-

-

-

477 days

303 days

-

Rotation tangible assets

-

-

-

-

476.70 %

321.59 %

-

 

Profitability of the business

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

SECTOR MEDIAN 2012

Margin trading

65.95 %

0%

0.00 %

0%

0.00 %

0.00 %

0%

Profitability of the business

13.50 %

-19.5 %

16.76 %

-3.4 %

17.35 %

6.72 %

100.9 %

Net profit

11.74 %

24.9 %

9.40 %

-34.1 %

14.26 %

3.14 %

273.9 %

Growth rate of turnover (excluding VAT)

4.88 %

-45.6 %

8.97 %

0%

0.00 %

3.60 %

35.6 %

Rates integration

34.52 %

-7.4 %

37.28 %

-0.3 %

37.39 %

33.64 %

2.6 %

Rate leasing furniture

0.00 %

0%

0.00 %

0%

0.00 %

0.00 %

0%

Work Factor

54.39 %

12.8 %

48.23 %

-1.7 %

49.05 %

63.04 %

-13.7 %

Weight interests

8.43 %

-8.6 %

9.22 %

13.5 %

8.12 %

0.43 %

1860.5 %

 

Return on capital

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

SECTOR MEDIAN 2012

Cash flow from the overall profitability

14.67 %

-10.1 %

16.31 %

-5.2 %

17.21 %

6.79 %

116.1 %

Rates of economic profitability

9.00 %

-25.0 %

12.00 %

0%

12.00 %

14.00 %

-35.7 %

Financial profitability

197,746,000.00 %

15.9 %

170,556,000.00 %

12.3 %

151,826,000.00 %

2,656,543.50 %

7343.7 %

Return on investment

13.33 %

-1.5 %

13.53 %

-16.0 %

16.10 %

7.92 %

68.3 %

 

Management intermediate balances

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

SECTOR MEDIAN 2012

Turnover

271,913,000

4.9 %

259,250,000

9.0 %

237,913,000

9,712,338

2699.7 %

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

SECTOR MEDIAN 2012

Sales of goods

271,913,000

0%

0

0%

0

-

- Purchase of goods

93,460,000

0%

0

0%

0

-

+/- Stock of goods variation

-868,000

0%

0

0%

0

-

Trading margin

179,321,000 €

0%

0 €

0%

0 €

0 €

0%

65.95 % CA

0%

0.00 % CA

0%

0.00 % CA

0.00 % CA

0%

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

SECTOR MEDIAN 2012

Sale of goods produced

0

0%

259,250,000

9.0 %

237,913,000

-

+/- Stocked production

2,620,000

4.8 %

2,499,000

20725.0 %

12,000

-

+ Self-constructed assets

0

0%

0

0%

0

-

Period production

2,620,000 €

-99.0 %

261,749,000 €

10.0 %

237,925,000 €

6,683,358 €

-60.8 %

0.96 % CA

-99.0 %

100.96 % CA

0.9 %

100.01 % CA

99.20 % CA

-99.0 %

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

SECTOR MEDIAN 2012

Trading margin

179,321,000

0%

0

0%

0

0

0%

+ Period Production

2,620,000

-99.0 %

261,749,000

10.0 %

237,925,000

6,683,358

-60.8 %

- Purchase of raw materials

0

0%

91,394,000

6.0 %

86,199,000

-

+/- Change in stocks of raw materiels

0

0%

-1,032,000

46.2 %

-1,919,000

-

- Other external purchases and charges

88,078,000

17.8 %

74,743,000

15.6 %

64,683,000

-

Added value

93,863,000 €

-2.9 %

96,644,000 €

8.6 %

88,962,000 €

2,917,163 €

3117.6 %

34.52 % CA

-7.4 %

37.28 % CA

-0.3 %

37.39 % CA

33.64 % CA

2.6 %

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

SECTOR MEDIAN 2012

Added value

93,863,000 €

-2.9 %

96,644,000 €

8.6 %

88,962,000 €

2,917,163 €

3117.6 %

+ Operating grants

0

0%

0

0%

0

-

- Tax, duty and similar payments

6,090,000

-7.6 %

6,589,000

62.7 %

4,050,000

-

- Personal charges

51,052,000

9.5 %

46,610,000

6.8 %

43,632,000

-

Gross operating surplus

36,721,000 €

-15.5 %

43,445,000 €

5.2 %

41,280,000 €

491,346 €

7373.6 %

13.50 % CA

-19.5 %

16.76 % CA

-3.4 %

17.35 % CA

6.72 % CA

100.9 %

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

SECTOR MEDIAN 2012

Gross operating surplus

36,721,000 €

-15.5 %

43,445,000 €

5.2 %

41,280,000 €

491,346 €

7373.6 %

+ Release of reserves and provisions

3,392,000

78.0 %

1,906,000

-41.9 %

3,278,000

-

+ Other operating income

8,817,000

20.8 %

7,299,000

23.8 %

5,895,000

-

- Depreciation/ Amortisation

9,752,000

8.2 %

9,015,000

7.9 %

8,352,000

-

- Other charges

1,186,000

19.6 %

992,000

-61.3 %

2,564,000

-

Operating result

37,992,000 €

-10.9 %

42,643,000 €

7.9 %

39,537,000 €

224,352 €

16834.1 %

13.97 % CA

-15.1 %

16.45 % CA

-1.0 %

16.62 % CA

4.34 % CA

221.9 %

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

SECTOR MEDIAN 2012

Operating result

37,992,000 €

-10.9 %

42,643,000 €

7.9 %

39,537,000 €

224,352 €

16834.1 %

+/- Result of joint-venture transferred from/to other partners

0

0%

0

0%

0

-

+ Financial income

26,000,000

11.8 %

23,262,000

-17.3 %

28,114,000

-

- Financial charges

22,923,000

-4.1 %

23,900,000

23.7 %

19,324,000

-

Pre-tax result

41,069,000 €

-2.2 %

42,005,000 €

-13.1 %

48,327,000 €

189,296 €

21595.7 %

15.10 % CA

-6.8 %

16.20 % CA

-20.2 %

20.31 % CA

3.99 % CA

278.4 %

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

SECTOR MEDIAN 2012

Extraordinary income

902,000

-55.6 %

2,030,000

320.3 %

483,000

19,628

4495.6 %

- Extraordinary charges

1,024,000

-54.7 %

2,258,000

87.4 %

1,205,000

-

Extraordinary result

-122,000 €

46.5 %

-228,000 €

68.4 %

-722,000 €

0 €

0%

-0.04 % CA

55.6 %

-0.09 % CA

70.0 %

-0.30 % CA

-0.01 % CA

-300.0 %

 

31/12/2012

Variation

31/12/2011

Variation

31/12/2010

SECTOR MEDIAN 2012

Pre-tax result

41,069,000 €

-2.2 %

42,005,000 €

-13.1 %

48,327,000 €

189,296 €

21595.7 %

Extraordinary result

-122,000 €

46.5 %

-228,000 €

68.4 %

-722,000 €

0 €

0%

- Employee profit sharing

3,882,000

-34.2 %

5,901,000

73.6 %

3,399,000

-

- Tax on profits

5,135,000

-55.4 %

11,507,000

11.8 %

10,291,000

-

Net result

31,930,000 €

31.0 %

24,369,000 €

-28.1 %

33,915,000 €

152,838 €

20791.4 %

11.74 % CA

24.9 %

9.40 % CA

-34.1 %

14.26 % CA

3.14 % CA

273.9 %

 

Synthesized Accounts

 

31/12/2012

Account period (month)

12

Account Type

Consolidated

Activity Code

2120Z

 

Active account

 

31/12/2012

Capital not called

0

Total fixed assets

298,829,000

 Intangible assets

111,269,000

 Tangible assets

130,293,000

 Financial assets

9,076,000

Net current assets

342,321,000

 Stocks

100,379,000

 Advanced payments

0

 Receivables

178,180,000

 Securities and cash

63,762,000

Accounts of regularization

0

Total Assets

641,151,000

 

Passive account

 

31/12/2012

Shareholders' equity

165,979,000

Share capital

40,332,000

Other capital resources

0

Risk Provisions

4,872,000

Liabilities

465,487,000

 Financial liabilities

389,982,000

 Advanced payments received

0

 Trade account payables

75,505,000

 Tax and social liabilities

0

 Other debts and fixed assets liabilities

0

Account regularization

0

Total liabilities

641,151,000

 

Results

 

31/12/2012

Sales of Goods

592,839,000

Net turnover

589,662,000

 of which net export turnover

0

Operating charges

509,351,000

Operating profit/loss

83,488,000

Financial income

0

Financial charges

12,845,000

Financial profit/loss

-12,845,000

Pretax net operating income

70,643,000

Extraordinary income

0

Extraordinary charges

6,046,000

Extraordinary profit/loss

-6,046,000

 

Consolidation

 

31/12/2012

Net result before amortisation of goodwill

44,431,000

Goodwill amortisation allocation

-7,178,000

Net result of equity affiliates companies

0

Net result of integrated companies

0

Group result (consolidated net result)

37,253,000

Share of minority interest (Result except group)

2,694,000

Net result - group share (part of parent company)

34,561,000

 

 

Accounts – Active

 

Normal Account

 

31/12/2012

Account period (month)

12

 

Grand Total - Active Accounts (I to VI)

 

31/12/2012

Grand Total (I to VI)

Net

641,151,000

Gross

CO

785,720,000

Amortisation

1A

144,569,000

 

Capital subscribed not called (I)

 

31/12/2012

Capital suscribed not called (I)

AA3

0

 

Active fixed asset (II)

 

31/12/2012

Total Active fixed asset (II)

Net

298,829,000

Gross

BJ

427,758,000

Amortisation

BK

128,929,000

 

Intangible fixed assets

 

31/12/2012

Start-up cost

Net

0

Gross

AB

0

Amortisation

AC

0

R&D expenses

Net

0

Gross

CX

0

Amortisation

AE

0

Distributorships, patents

Net

92,318,000

Gross

AF

122,702,000

Amortisation

AG

30,384,000

Goodwill

Net

0

Gross

AH

0

Amortisation

AI

0

Other intangible fixed assets

Net

18,951,000

Gross

AJ

18,951,000

Amortisation

AK

0

Pre-payments and downpayments

Net

0

Gross

AL

0

Amortisation

AM

0

Sub Total Intangible asset

Net

111,269,000

 

Tangible fixed assets

 

31/12/2012

Acquisition difference

Net

47,640,000

Gross

A11

47,640,000

Amortisation

A12

0

Goodwill

Net

0

Gross

A21

0

Amortisation

A22

0

Difference from the first consolidation

Net

0

Gross

A31

0

Amortisation

A32

0

Lands

Net

0

Gross

AN

0

Amortisation

AO

0

Buildings

Net

0

Gross

AP

0

Amortisation

AQ

0

Plant

Net

0

Gross

AR

0

Amortisation

AS

0

Other tangible fixed assets

Net

130,293,000

Gross

AT

228,801,000

Amortisation

AU

98,508,000

Fixed assets in construction

Net

0

Gross

AV

0

Amortisation

AW

0

Advances and payments on account

Net

0

Gross

AX

0

Amortisation

AY

0

Sub Total Tangible asset

Net

177,933,000

 

Financial assets

 

31/12/2012

Associates at equity

Net

0

Gross

CS

0

Amortisation

CT

0

Other participations

Net

693,000

Gross

CU

730,000

Amortisation

CV

37,000

Inter-company receivables

Net

0

Gross

BB

0

Amortisation

BC

0

Other investment securities

Net

0

Gross

BD

0

Amortisation

BE

0

Loans

Net

0

Gross

BF

0

Amortisation

BG

0

Other financial assets

Net

8,383,000

Gross

BH

8,383,000

Amortisation

BI

0

Other financial assets

Net

551,000

Gross

A41

551,000

Amortisation

A42

0

Sub Total Financial assets

Net

9,627,000

 

Current Assets (III)

 

31/12/2012

Total Assets

Net

342,321,000

Gross

CJ

357,961,000

Amortisation

CK

15,640,000

 

Stocks

 

31/12/2012

Raw materials

Net

100,379,000

Gross

BL

107,178,000

Amortisation

BM

6,799,000

Work in progress (goods)

Net

0

Gross

BN

0

Amortisation

BO

0

Work in progress (services)

Net

0

Gross

BP

0

Amortisation

BQ

0

Semi-finished and finished products

Net

0

Gross

BR

0

Amortisation

BS

0

Goods for resale

Net

0

Gross

BT

0

Amortisation

BU

0

Sub Total Stocks

Net

100,379,000

 

Advance payments to suppliers

 

31/12/2012

Advance payments to suppliers

Net

0

Gross

BV

0

Amortisation

BW

0

 

Debtors

 

31/12/2012

Trade accounts receivable

Net

105,614,000

Gross

BX

114,455,000

Amortisation

BY

8,841,000

Other debtors

Net

69,662,000

Gross

BZ

69,662,000

Amortisation

CA

0

Capital subscribed and called up

Net

0

Gross

CB

0

Amortisation

CC

0

Sub Total debtors

Net

175,276,000

 

Divers

 

31/12/2012

Investment securities

Net

38,217,000

Gross

CD

38,217,000

Amortisation

CE

0

Cash and cash equivalents

Net

25,545,000

Gross

CF

25,545,000

Amortisation

CG

0

Sub Total Divers

Net

0

 

Prepaid expenses

 

31/12/2012

Prepaid expenses

Net

2,904,000

Gross

CH

2,904,000

Amortisation

CI

0

 

Equalization accounts (IV to VI)

 

31/12/2012

Multi-period charges

CW3

0

Premiums on redemption of bonds

CM3

0

Currency differential gain

CN3

0

 

References

 

31/12/2012

Due within one year

CP

0

Due after one year

CR

0

 

 

Accounts – Passive

 

Grand Total - Passive Accounts (I to IV)

 

31/12/2012

Grand Total (I to IV)

EE

641,151,000

 

Shareholder Equity (I)

 

31/12/2012

Total shareholders' equity (Total I)

DL

165,979,000

Equity and shareholders' equity

DA

40,332,000

Issue and merger premiums

DB

0

Revaluation differentials

DC

0

Of which equity differential

EK

0

Legal reserve

DD

0

Statutory or contractual reserve

DE

0

Special regulated reserves

DF

0

Other reserves

DG

110,070,000

Profits or losses brought forward

DH

0

Conversion differences

P1

-18,984,000

Net result - group part

P2

34,561,000

Investment grants

DJ

0

Special tax-allowable reserves

DK

0

 

Other capital resources (II)

 

31/12/2012

Total other capital resources (Total II)

DO

0

Income from participating securities

DM

0

Conditional loans

DN

0

Others

P3

0

 

Provisions for risks and charges (III)

 

31/12/2012

Total provisions for risks and charges (Total III)

DR

4,872,000

Conversion differences

P4

0

In reserves

P5

4,813,000

In results

P6

0

Total III

P7

4,813,000

Delayed tax

P8

4,872,000

Acquisition differences

P9

0

Risk provisions

DP

0

Reserves for charges

DQ

0

 

Liabilities (IV)

 

31/12/2012

Total Liabilities (Total IV)

EC

465,487,000

Convertible debentures

DS

0

Other debentures

DT

0

Bank loans and liabilities

DU

0

Sundry loans and financial liabilities

DV

389,982,000

Of which participating loans

EI

0

Advance payments received for current orders

DW

0

Trade accounts payables

DX

75,505,000

Tax and social security liabilities

DY

0

Fixed asset liabilities

DZ

0

Other debts

EA

0

 

Translation loss (V)

 

31/12/2012

Translation loss (Total V)

ED

0

 

Equalization accounts

 

31/12/2012

Deferred income

EB

0

 

References

 

31/12/2012

Of which tax-allowable reserve

EF

0

Deferred income and liabilities

EG

0

Of which current bank facilities

EH

0

 

 

Result account

 

1-     Operating result (I-II)

2-      

31/12/2012

Operating result (Total I-II)

GG

83,488,000

 

2 - Financial result (V - VI)

 

31/12/2012

Financial result (Total V-VI)

GV

-12,845,000

 

3 - Pre-tax net operating income result (I - VI)

 

31/12/2012

Pre-tax net operating income (Total I-II+II-IV+V-VI)

GW

70,643,000

 

4 - Extraordinary result (VII-VIII)

 

31/12/2012

Extraordinary result (Total VII-VIII)

HI

-6,046,000

 

Consolidation

 

31/12/2012

Delayed tax

R1

-668,000

Net result before amortisation of acquisition differences

R2

44,431,000

Endowment to amortisation of acquisition differences

R3

-7,178,000

Net result of companies set in equivalence

R4

0

Net result of integrated companies

R5

0

Group result (consolidated net result)

R6

37,253,000

Cross-reference : equipment leasing

R7

2,694,000

Cross-reference : property leasing

R8

34,561,000

 

Operating income (I)

 

31/12/2012

Total operating income (Total I)

FR

592,839,000

 

Operating income (details)

 

31/12/2012

Sale of goods for resale

FC

589,662,000

France

FA

589,662,000

Export

FB

0

Sale of goods produced

FF

0

France

FD

0

Export

FE

0

Sale of services

FI

0

France

FG

0

Export

FH

0

Net turnover

FL

589,662,000

France

FJ

589,662,000

Export

FK

0

Stocked production

FM

0

Self-constructed assets

FN

0

Operating grants

FO

0

Release of reserves and provisions

FP

0

Other income

FQ

3,177,000

 

Operating charges (II)

 

31/12/2012

Total operating charges (Total II)

GF

509,351,000

 

Exploitation charges

 

31/12/2012

Purchase of goods for resale

FS

219,222,000

Change in stocks of goods for resale

FT

0

Purchase of raw materials

FU

0

Change in stocks of raw materials

FV

0

Other external purchases and charges

FW

285,890,000

Tax, duty and similar payments

FX

0

Payroll

FY

0

Social security costs

FZ

0

 

Depreciation

 

31/12/2012

Depreciation of fixed assets

GA

4,239,000

Amortisation of fixed assets

GB

0

Depreciation/amortisation of current assets

GC

0

Provisions for risks and charges

GD

0

 

Other charges

 

31/12/2012

Other charges

GE

0

 

Operating charges (III-IV)

 

31/12/2012

Share of joint-venture transferred to other partner(s) (Total III)

GH

0

Share of joint venture transferred from other partner(s) (Total IV)

GI

0

 

Financial income (V)

 

31/12/2012

Total financial income (Total V)

GP

0

Share financial income

GJ

0

Other investment income & capitalised receivables

GK

0

Other interest and similar income

GL

0

Released provisions and transferred charges

GM

0

Exchange gains

GN

0

Net income from disposal of investment securities

GO

0

 

Financial charge (VI)

 

31/12/2012

Total financial charge (Total VI)

GU

12,845,000

Financial reserves and provisions

GQ

0

Interest and similar charges

GR

12,845,000

Exchange losses

GS

0

Net loss from disposal of investment securities

GT

0

 

Extraordinary income (VII)

 

31/12/2012

Total extraordinary income (Total VII)

HD

0

Extraordinary operating income

HA

0

Extraordinary income from capital transactions

HB

0

Released provisions and transferred charges

HC

0

 

Extraordinary charges (VIII)

 

31/12/2012

Total extraordinary charges (Total VIII)

HH

6,046,000

Extraordinary operating charges

HE

6,046,000

Extraordinary charges from capital transactions

HF

0

Extraordinary reserves and provisions

HG

0

 

Employee profit sharing (IX)

 

31/12/2012

Employee profit sharing (Total IX)

HJ

0

 

Tax on profits (X)

 

31/12/2012

Tax on profits (Total X)

HK

20,834,000

 

References

 

31/12/2012

Of which equipment leases

HP

0

Of which property leases

HQ

0

 

 

Ratios

 

Structure and Liquidity

 

31/12/2012

Fixed Asset Financing

1.61

Global Debt

284.19 days

Working Capital Fund overall net

159.96 days

Financial independence

0.00 %

Solvability

25.89 %

 

Management or rotation

 

31/12/2012

Need background in operating working capital

122.20 days

Treasury

38.93 days

Inventory turnover of goods

0.00 days

Inventory turnover of raw materials in industrial enterprises

0.00 days

Inventory turnover of intermediate and finished products in the industrial enterprise

0.00 days

 

Profitability of the business

 

31/12/2012

Margin trading

589,661,962.82 %

Profitability of the business

14.34 %

Rates integration

14.34 %

Rate leasing furniture

0.00 %

Weight interests

2.18 %

 

Return on capital

 

31/12/2012

Rates of economic profitability

15.21 %

 

 

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.63.89

UK Pound

1

Rs.99.10

Euro

1

Rs.70.12

 

INFORMATION DETAILS

 

Analysis Done by :

KAR

 

 

Report Prepared by :

ASH

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.